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Gene delivery, the introduction of DNA into cells, is applicable to gene therapy, DNA
vaccination, functional genomics and diagnostics, tissue engineering, and drug-eluting medical
devices. Particulates incorporating DNA are promising vehicles for gene delivery and overcome
some of the barriers that hinder successful gene transfer, with the ability to protect DNA and
provide for controlled, localized, and sustained release and transfection. Furthermore, innovative
new gene delivery strategies that incorporate DNA particulates or complexes within films or
coatings for devices and scaffolds could further provide for controlled and sustained transfection
at the site of implant. Zein, a hydrophobic protein from corn, has many unique properties that
make it a promising candidate material for both particulate- and film-mediated gene delivery,
including its ability to easily form both nanospheres and films. Zein/DNA nanospheres, formed
through a simple coacervation process, demonstrated the ability to protect DNA against
nucleases, displayed robust biocompatibility, and were able to be internalized by cells. In
addition, zein films were developed for substrate-mediated gene delivery. Zein films were
formed by evaporation- induced self-assembly and were comprised of particles that increased in
size with zein concentration, up to 1.8 0.11 nm in diameter. Films formed at different pH
values (2-12) resulted in morphological differences, from a smooth surface at pH 2 to films
composed of spheres that decreased in size as the pH of the zein solution used to form the film

increased. Zein films degraded minimally in PBS, and were able to adsorb DNA complexes
formed with cationic lipids or cationic polymers, with 0.4 µg and 1.12 µg of total DNA on film
surface for lipid/DNA and polymer/DNA complexes, respectively, which was independent of
pH. However, transfection levels increased on films with increasing pH and highest gene
expression was achieved on pH 9 films with lipid/DNA complexes. This increase in transfection
on pH 9 films could be attributed to the decreased surface roughness and increased
hydrophilicity of the film. Both the zein spheres and films investigated in this thesis display great
potential for gene delivery applications, in particular for oral and intramuscular gene delivery
and as a surface-coating for biomedical devices.
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CHAPTER 1: Introduction to Gene Delivery and Zein
1.1 Introduction
Nonviral gene delivery is the introduction of exogenous DNA into cells through the use
of nonviral vectors for subsequent gene expression and is applicable to the fields of gene
therapy, DNA vaccination, functional genomics and diagnostics, and biomedical devices.
Nonviral gene delivery systems include naked DNA, chemical vectors and particulates,
which are delivered typically through a bolus addition to cells or through substratemediated delivery, where DNA vectors are adsorbed to a biomaterial substrate. However,
nonviral vectors are often inefficient and their lack of efficacy in nonviral systems can be
attributed to a variety of barriers and prevents their use in widespread applications. Some
of these barriers to gene delivery systems include protection of DNA against degradation
from nucleases or enzymes, appropriate degradation rates of DNA vectors and carriers,
and providing sustained delivery of DNA to the target. The use of particulates
incorporating DNA, which can be delivered as distinct spheres or used to form particulate
composite films, are promising vehicles for gene delivery, with the ability to protect
DNA and provide for controlled, localized, and sustained release and transfection. Zein, a
hydrophobic protein from corn, is biocompatible and has properties that make it a
promising candidate material for particulate delivery, including its ability to form both
nanospheres and films through coacervation or evaporation induced self-assembly,
respectively. Due to the promise of this natural biomaterial for drug and gene delivery,
the objectives of this thesis were to: 1) further investigate DNA-loaded zein nanospheres
for their ability to protect cargo from nucleases, as well as their biocompatibility and the
ability of cells to internalize the spheres, and 2) develop zein films for substrate-mediated
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gene delivery. The zein spheres and films investigated in this thesis show great potential
to revolutionize applications in oral and intramuscular gene delivery and as a surfacecoating for biomedical devices, respectively.

1.2 Gene Delivery
Gene delivery is the introduction of exogenous DNA to host cells for subsequent gene
expression and is applicable to the fields of gene therapy (Niidome and Huang 2002),
DNA vaccination (Donnelly, Ulmer et al. 1997), functional genomics and diagnostics
(Pannier, Ariazi et al. 2007), tissue engineering (Shea, Smiley et al. 1999) and medical
implants (Zilberman, Kraitzer et al. 2010). Gene delivery methods are broadly classified
into two categories, viral and nonviral. Viral methods have a known history of being
effective by achieving high rates of transduction, as well as stable expression levels that
have led to limited success in clinical trials (Thomas, Ehrhardt et al. 2003; Ginn,
Alexander et al. 2013). However, several fundamental problems are associated with the
use of viral vectors including toxicity, immunogenicity, endogenous virus recombination,
oncogenic effects, limited transgene size, complexity of fabrication and lack of cellspecific targeting (Thomas, Ehrhardt et al. 2003; Gao, Kim et al. 2007). In addition,
despite therapeutic effects, patient deaths have been reported from the use of viral gene
delivery (Thomas, Ehrhardt et al. 2003). Hence, there is a need to investigate new vectors
and methods of gene delivery. The development of nonviral gene vectors circumvents
some of these safety concerns and technical drawbacks of viral vectors. Advantages of
nonviral vectors include simplicity of preparation, easy scale-up for mass production,
flexibility in transgene size capacity, low immunogenicity, biocompatibility, and cost

3

effectiveness (Niidome and Huang 2002; Wiethoff and Middaugh 2003). However,
nonviral vectors exhibit significantly reduced transfection rates (expression of the
delivered genes) when compared to viral delivery systems (Wiethoff and Middaugh
2003). Most researchers in the field would agree that the major challenge of nonviral
gene delivery is the issue of efficient delivery.

The extracellular and intracellular barriers associated with these processes (Figure 1-1)
that must be overcome for successful gene delivery are, for the most part, common to all
delivery systems. Successful delivery of DNA by any system requires cellular
internalization, enodsomal escape, nuclear localization and production of the therapeutic
protein encoded by the gene (Ledley 1995). Packaged DNA must first be internalized by
endocytosis for complexes (Mintzer and Simanek 2009) or phagocytosis for microspheres
(Agarwal and Mallapragada 2008). After internalization, the DNA must escape the
endosome without being degraded by low pH, nucleases or enzymes and then navigate
through the cytosol to the nucleus. Nuclear localization and entry into the nucleus are
subsequently needed in order to lead to the production of the protein from the delivered
gene (De Laporte, Cruz Rea et al. 2006). At some point during the endosomal
escape/nuclear localization process, the DNA must disassociate from the complex or be
released from the nano- or microsphere to allow expression (Pichon, Billiet et al. 2010).
In vivo transfection is further complicated by instability of complexes under
physiological conditions and adsorption of serum proteins prior to cellular internalization
(Mintzer and Simanek 2009). Unlike viral vectors that have evolved to overcome most of
these cellular barriers to gene delivery, nonviral vectors are still hindered by them

4

(Mintzer and Simanek 2009). In addition to these cellular barriers, even more barriers
exist when gene delivery is considered in the context of whole organism for certain
delivery routes, for example the different pH environments of the gastrointestinal tract for
oral gene delivery. It is important to understand that one delivery vector cannot possibly
be effective for all the different applications of gene delivery and thus there is a need for
designing efficient and safe delivery systems that take into account these barriers and
include tactics to overcome them.

Figure 1-1. Barriers to nonviral gene delivery mechanism (courtesy of T. Kasputis).

1.3 Nonviral Delivery Systems
Nonviral delivery of DNA is typically accomplished by one of three delivery systems:
naked DNA, chemical vectors and particulates. Each system has advantages and
disadvantages depending on the intended application.

5

1.3.1 Naked DNA
The injection of naked DNA is perhaps the simplest and most non-toxic delivery system,
but often requires addition of a physical approach such as electroporation (Rols, Delteil et
al. 1998) or the use of a gene gun (Yang, Burkholder et al. 1990) to help the DNA
penetrate the cell membrane before degradation by nucleases occurs (Niidome and Huang
2002). Successful delivery of naked DNA in vivo was first discovered by Wolff et al
when plasmid DNA was injected into the muscle of a mouse and induced protein
production (Wolff J.A 1990). Intramuscular injection of naked DNA has been used to
introduce the dystrophin gene into animal models of Duchenne muscular dystrophy and
yielded long-term gene expression in a limited number of muscle fibers and protection of
those fibers against degeneration (Acsadi, Dickson et al. 1991; Danko, Fritz et al. 1994).
However, the delivery of naked DNA achieves low levels of gene expression, mainly
localized along the track of injection (Ledley 1995), compared to other forms of DNA
delivery (Ledley 1996). This limited uptake and expression could be due to the large size
of DNA and the repulsion of the negatively charged DNA and negatively charged cellular
membranes (Segura and Shea 2001). Therefore this technique may be appropriate when
limited transfection is acceptable such as DNA vaccination (Cotten and Wagner 1994).
Approaches to enhance DNA delivery by not only overcoming the extracellular and
intracellular barriers mentioned above but also that of stability, size, charge density and
biodistribution of DNA have been investigated through the use of chemical vectors and
particulates (Segura and Shea 2001). The remainder of this thesis will focus on the
improvement and use of chemical vectors and particulates for DNA delivery.
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1.3.2 Chemical Vectors
Nonviral chemical vectors deliver DNA by forming a DNA complex, which condenses
the DNA and neutralizes the charge, typically by cationic polymers or lipids (Mintzer and
Simanek 2009). Two commonly used chemical vectors for delivery of DNA include a
cationic polymer, polyethylenimine (PEI) and a cationic lipid, Lipofectamine (LF)
(Segura and Shea 2001). Cationic polymers, such as PEI, condense DNA by electrostatic
interactions between the positively charged polymer and negatively charged DNA
forming net positively charged polyplexes, which are less than 100 nm. PEI exists in
either branched or linear conformation but branched PEI at a molecular weight of 25 kDa
has become the most commonly used due it its high transfection efficiency. Some of the
success of PEI has been attributed to its endosomal buffer capacity which aids the release
of the polyplex into the cytosol (Mintzer and Simanek 2009). The efficiency of PEI/DNA
complexes is influenced by PEI material properties such as molecular weight and degree
of branching, but also the polyplex properties including the N/P ratio (ratio of nitrogen
atoms of PEI to DNA phosphates), concentration of DNA, size and zeta potential
(Lungwitz, Breunig et al. 2005). PEI/DNA complexes are known to be more toxic than
the use of cationic lipids, such as LF, as a nonviral gene delivery vector.

Cationic lipids complex with DNA also via electrostatic interactions of the positively
charged head of the lipid moiety and negatively charged phosphate backbone of the DNA
to form lipoplexes of DNA and lipid (Segura and Shea 2001). This method condenses the
DNA, resulting in a positively charged lipoplex that can interact with the negatively
charged cell membrane, aiding in increased cellular uptake and expression levels (Segura
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and Shea 2001). Lipofectamine2000 (LF2000) is a commercially available cationic lipid
and widely used in many labs due to its effectiveness in producing high transfection
efficiencies in certain cell lines when optimized (Plautz, Boanca et al. 2011).
Optimization of lipoplexes involves fine-tuning of the ratio of cationic lipid to DNA,
amount of DNA, and delivery volume, which ultimately affects the size, charge and
stability of the lipoplex. Cationic lipids have been shown to be more efficient at delivery
of DNA than cationic polymers and used in several clinical trials for treatment of cancer
(Nabel, Nabel et al. 1993) and cystic fibrosis (Caplen, Alton et al. 1995). Drawbacks of
lipoplexes involve the physiochemical properties of the lipoplex in vivo due to the
presence of salts and other molecules that could lead to aggregation and dissociation of
lipoplexes and result in reduced bioavailability, cellular uptake and transfection
efficiencies (Ledley 1995). Therefore, specific delivery strategies are needed to sustain
the optimal properties while overcoming the barriers of the lipoplexes to enhance cellular
uptake and transection. In this thesis, lipoplexes (using LF2000) and polyplexes (using
PEI) were used to deliver DNA by substrate-mediated delivery (described below) on zein
films.

1.3.3 Particulates
Particulates are an alternative to chemical vectors for DNA delivery, which consist of
polymers that encapsulate DNA or DNA complexes within or throughout a particle, or
through adsorbing/conjugating DNA to the surface of the particle (Panyam and
Labhasetwar 2003). The use of particulates for DNA delivery provides numerous
advantages such as protection of DNA against degradation, sustained DNA release, and
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tissue targeting abilities (Panyam and Labhasetwar 2003; Agarwal and Mallapragada
2008). Using particulates to encapsulate DNA can shield it from the immune system,
DNA nucleases, and degradation from different pH and enzymes, such as those found in
the gastrointestinal (GI) tract, which can improve the in vivo response and transfection
efficiency of the delivery system by increasing the residence time of the DNA-loaded
particles (Agarwal and Mallapragada 2008). Particulates can be internalized by cells
(nanoparticles) or phagocytized (microparticles), depending on their size and can serve as
transgene depots inside the cell (Pannier and Shea 2004). Particles release their cargo
through a combination of diffusion and degradation of the polymer matrix (Agarwal and
Mallapragada 2008) and thus the delivery system can be tailored to a particular
application through the polymer choice (Segura and Shea 2001). Both natural and
synthetic polymers have been researched as nanocarriers for DNA. Natural polymers
have the advantages of providing innate degradability and bioactivity (Dang and Leong
2006; Malafaya, Silva et al. 2007), but typically suffer from insufficient mechanical
properties, poor water stability, limited ability to be processed, and a relatively short
release period compared to synthetic polymers (Panyam and Labhasetwar 2003; Yannas
2004). However, some natural polymers derived from plants, including wheat gluten,
glutenin, zein, soy protein, cellulose, and starch (Czaja, Young et al. 2006; Malafaya,
Silva et al. 2007; Reddy and Yang 2011) overcome some of the shortcomings of other
natural polymers. Among the various plant proteins, zein, the prolamin or storage protein
from corn, has properties that make it a promising candidate material for particulate
delivery and was investigated in this thesis for application in gene therapy or DNA
vaccination.
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1.4 Delivery Strategies for in Vitro Transfection
Controlled and efficient delivery of DNA complexes or particulates loaded with DNA is
an essential aspect in both basic and advanced applications gene delivery. In addition to
choice of vector or particulate material, the delivery strategy is an important factor
involved in enhancing gene expression. Currently, there are two main strategies for
delivering DNA to cells, conventional bolus delivery and substrate-mediated delivery
(SMD). The most common strategy is bolus delivery, where the nonviral DNA
complexes or particulates are employed in vitro as a “bolus” addition to the media
(Tseng, Haselton et al. 1997; Varga, Hong et al. 2001). Bolus delivery, which is also
analogous to intravenous (IV) in vivo delivery, has been widely utilized to study gene
function and screen for efficient delivery vehicles (Pannier and Segura 2013). However, a
major limitation is in mass transport of DNA to the cells, leading to the use of a large
amounts of DNA vectors, which cause toxicity (Luo and Saltzman 2000). Also bolus
delivery cannot be used to control which cells ultimately express the gene (without the
use of targeting ligands) and may not result in efficient gene delivery for all cell types
(Pannier and Segura 2013).

In the process of developing controlled and efficient gene delivery systems and strategies,
it has been shown that increased transfection can be achieved through increasing the
concentration of DNA in the cellular environment (Varga, Hong et al. 2001). Therefore,
an alternative technique of delivering DNA to cells, known as SMD (Segura and Shea
2002), reverse transfection (Ziauddin and Sabatini 2001), or solid-phase delivery
(Bielinska, Yen et al. 2000) involves the immobilization and maintenance of DNA or
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DNA complexes to the surface of a substrate, onto which cells are seeded. This
mechanism has shown to increase the concentration of DNA in the cellular environment
resulting in enhanced gene delivery and increased cell viability (Bengali, Pannier et al.
2005). SMD limits aggregation of DNA complexes by their immobilization and places
DNA vectors in direct contact with the cell to reduce mass transport limitations (Segura
and Shea 2002; Segura, Volk et al. 2003; Bengali, Pannier et al. 2005; Bengali and Shea
2005; Pannier, Anderson et al. 2005; Jang, Bengali et al. 2006; Bengali, Rea et al. 2007;
Pannier, Wieland et al. 2008; Bengali, Rea et al. 2009; De Laporte, Lei Yan et al. 2009).
SMD also allows for local and patterned delivery (Pannier, Anderson et al. 2005;
Houchin-Ray, Whittlesey et al. 2007). Furthermore, the adsorption of extracellular
matrix (ECM) proteins, such as fibronectin, onto substrates prior to the addition of DNA
complexes can increase DNA complex immobilization and transgene expression
(Bengali, Rea et al. 2007). SMD is a rising technique in the field of gene delivery and has
great potential in applications such tissue engineering, biomedical devices, and
transfected cell arrays. Thus, the use of zein was investigated in Chapter 3 in this thesis,
as a potential surface-coating material for substrate-mediated gene delivery on
biomedical devices and scaffolds.

1.5 Applications of Gene Delivery
Once delivery systems and strategies are fully optimized and result in high levels of
transfection in vitro, they then can be utilized for various gene delivery routes and
clinical applications. Here, the oral and intramuscular routes will be discussed as they are
most applicable to the zein spheres developed in this thesis for applications in gene
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therapy and DNA vaccination. While zein films were investigated in this thesis for local
gene delivery in applications such as functional genomics and diagnostics, tissue
engineering and drug-eluting biomedical devices.

1.5.1 Gene Therapy
The ultimate goal of gene therapy is to produce the stable expression of a correct
functioning gene (Drugan A 1987), in cases where the normal gene is deficient and the
therapy may be accomplished via one of three approaches: the modification of existing
genetic material, removal of genetic material or addition of genetic material. Gene
therapy was first perceived as a treatment or cure for hereditary single-gene defects
(monogenic disorders) like cystic fibrosis and hemophilia (Kay and Woo 1994), but has
expanded its potential to include acquired diseases such as cancer (Lowenstein 1997),
cardiovascular disease (Isner 2002), neurodegenerative disorders (Baekelandt, De
Strooper et al. 2000) and infectious disease (Bunnell and Morgan 1998). Currently, there
have been over 1800 gene therapy trials worldwide, either completed, ongoing or
approved, and 81.5% of those trials address cancer (64.4%), cardiovascular disease
(8.7%) and inherited monogenic disease (8.4%) (Ginn, Alexander et al. 2013). Also, of
those 1800 trials, 66.8% used viral vectors and the two most popular nonviral vectors
used were naked plasmid (18.3%) and lipofection (5.9%) (Ginn, Alexander et al. 2013).
The two most promising results in the clinic have been targeting diseases in the
hematopoietic system, adenosine deaminase- severe combined immunodeficiency (ADASCID) and X-linked adrenoleukodystrophy (X-ALD), with over 30 patients treated with
ADA-SCID (Gaspar, Aiuti et al. 2009; Ferrua, Brigida et al. 2010) and two young
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patients treated with X-ALD (Cartier, Hacein-Bey-Abina et al. 2009). Viral vectors were
used for both of these clinical trials. These numbers highlight the exciting therapeutic
progress that is being made in the field of gene therapy but also the need to develop more
efficient delivery systems. In addition, the diversity of targets for treatment of the
numerous diseases elucidates the notion that a single vector, viral or nonviral, cannot be
appropriate for all applications. Thus there is need to investigate new vectors, specifically
nonviral vectors due to their advantages mentioned above, in order to move the field of
gene therapy into clinical reality. New nonviral vectors are commonly investigated for
DNA delivery through the oral or intramuscular route.

1.5.1.1 Oral route
Delivery of DNA via the oral route is an appealing delivery method due to its associated
high patient compliance, with convenience in both non-invasiveness and in control of
dosing (frequency and strength) (Shahiwala 2011). The oral route has the additional
advantages of presenting a large surface area intestinal epithelium for transfection and
allowing treatment of regional disorders by providing access to the luminal side of the
intestine (Bhavsar and Amiji 2007). Oral gene delivery has the potential to treat diseases
associated with the gastro-intestinal tract (GI-tract) such as colon cancer, cystic fibrosis,
inflammatory bowel disease and Crohn’s disease (Page and Cudmore 2001) as well as
systemic diseases (Rothman, Tseng et al. 2005). However, efficient and consistent gene
expression mediated by oral DNA delivery is complicated by a number of physiological
barriers associated with GI-tract, including low pH in the stomach and DNases in the
intestine (Loretz, Foger et al. 2006), which can degrade unprotected DNA. Particulates
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are considered a viable tool for the protection of DNA from the harsh environment of
both the stomach and intestine (Chen and Langer 1998). Previous studies have focused on
poly(lactide-co-glycolide) (PLGA) and chitosan to form DNA-loaded nano- and
microspheres for oral gene delivery (Jones, Clegg et al. 1998; Roy, Mao et al. 1999;
Agarwal and Mallapragada 2008; Bowman, Sarkar et al. 2008). While these delivery
vehicles have been shown to elicit the production of a therapeutic or immune response
inducing protein, the level of protein produced is often modest with high variability (He,
Wang et al. 2005; Bowman, Sarkar et al. 2008). Furthermore, although these materials
have provided a valuable proof of concept, their lack of sufficient efficacy suggests that
new polymers need to be investigated to overcome the multiple barriers of oral gene
delivery. Hence, Chapter 2 focuses on the use of zein as a DNA particulate for
applications in oral gene delivery.

1.5.1.2 Intramuscular route
Skeletal muscle comprises 40% of total body mass and skeletal myocytes have a long
half-life in vivo, thus the readily availability and stable platform of muscle creates a
promising target tissue for gene delivery (Marshall and Leiden 1998). The direct
injection of DNA delivery systems into muscle has been investigated for gene therapy to
treat serum-protein deficiencies, muscular dystrophies and chronic ischemic limb
syndromes (Tripathy, Svensson et al. 1996). However, as for oral delivery of DNAloaded particulates, lack of sufficient efficacy with intramuscular administration suggests
that new polymers need to be investigated for DNA delivery. Thus, zein was investigated
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in Chapter 2 as a DNA-loaded particulate for application in intramuscular delivery, in
addition to its potential use in oral delivery.

1.5.2 DNA Vaccination
Vaccination is the introduction of antigenic material designed to provoke an individual’s
immune response and generate immunity to a pathogen (Gurunathan, Klinman et al.
2000). The introduction of vaccinations against smallpox, diphtheria, pertussis, tetanus,
polio, measles, rubella, and mumps have had a large impact on human health, decreasing
mortality and morbidity rates from infectious diseases (O'Hagan and Rappuoli 2004).
Success from these vaccinations is from the induction of long-lived antibody response
through humoral immunity (Gurunathan, Klinman et al. 2000), which is typically
mediated by recognition of specific antigens and antibody production from B
lymphocytes. Nevertheless, vaccinations against intracellular organisms that require cellmediated immunity are not available or are inefficient for clinical use. Cell-mediated
immunity does not involve antibodies but activates cytotoxic T-lymphocytes (CTL).
Therefore, there is a need to develop new vaccines against infectious diseases such as
tuberculosis, malaria, and human immunodeficiency virus (HIV) that induce cellular
immunity response. Research into vaccination approaches has included the use of
attenuated live vaccines that employ recombinant viruses or bacteria, and genetic
vaccines which consist of DNA (Leitner, Ying et al. 1999). In contrast to other vaccine
types, genetic vaccinations are plasmid DNA vectors encoding genes for antigens that
will produce an immune response. DNA vaccines hold great potential not only because of
the safety profile but also due to ease of manufacturing and purifying, and low cost of
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production (O'Hagan, Singh et al. 2004). The direct injection of DNA delivery systems
into muscle has been investigated for DNA vaccination (O'Hagan and Rappuoli 2004). In
addition, DNA vaccines have demonstrated the induction of both humoral and cellular
immune responses in various animal models (Ulmer, Donnelly et al. 1993; Donnelly,
Ulmer et al. 1997; Gurunathan, Klinman et al. 2000). However, DNA vaccine potency in
large animal and human systems is lacking due to the inefficient delivery of DNA to
effectively invade antigen presenting cells (APC), resist degradation by extracellular
nucleases and self-replicate (Leitner, Ying et al. 1999) .

An approach to overcome these delivery barriers of DNA vaccines is the use of
biodegradable polymeric microparticles to entrap the DNA. Microparticles are taken up
efficiently in vivo and in vitro by APC and have also been shown to exert an adjuvant
(improve immunogenicity of antigen) effect for the induction of cell-mediated immunity
through CTL responses (O'Hagan and Rappuoli 2004; O'Hagan, Singh et al. 2004).
Injection of DNA-loaded nanoparticles or microparticles into muscle primarily results in
local transfection because the particles do not readily diffuse from the tissue, but can
serve as a depot releasing the encoded protein into circulation (Tripathy, Svensson et al.
1996). Particulate DNA delivery vehicles have been shown to increase the magnitude and
duration of transgene expression compared to other delivery vehicles or naked DNA
administered intramuscularly (Wang, Zhang et al. 2002; Agarwal and Mallapragada
2008). A commonly used polymer for DNA vaccination has been PLGA, which can be
delivered systemically or to mucosal surfaces such as GI- or respiratory- tract (O'Hagan,
Singh et al. 2004). However, progress in clinical evaluation of DNA microparticle
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delivery has been limited by a variety of problems in areas such as maintenance of DNA
integrity during encapsulation, ability for controlled release, and low DNA encapsulation
and loading (Dubensky, Liu et al. 2000; Gurunathan, Klinman et al. 2000; O'Hagan and
Rappuoli 2004; O'Hagan, Singh et al. 2004). Hence, the development of efficient
delivery systems through the consideration of new polymers to overcome the current
drawbacks of microparticle DNA vaccines should be explored. Zein nanoparticles
capable of transfection would be a potential DNA vaccine delivery system, and were
investigated in this thesis.

1.5.3 Functional Genomics & Diagnostics
The goal of functional genomics and resulting diagnostics is to understand the
relationship between an organism’s genome and phenotype through the dynamic aspects
of gene transcription, translation and protein-protein interactions. Identifying targets for
the treatment of human disease requires functional characterization of the products
encoded by genes (Bailey, Wu et al. 2002). The use of transfected cell arrays (TCA) is a
powerful method that has allowed for high-throughput of genomic data through
transfection by several thousand different DNA molecules in microarray format. TCAs
involve the immobilization of DNA probes onto specific sites of a substrate, then cells
are seeded on top of the microarray and express defined gene products (Ziauddin and
Sabatini 2001; Bellis, Peňalver-Bernabé et al. 2011). Advantages of TCAs allow for
scaled down quantities of reagents and samples, long-term storage before transfection,
and analysis of individual cells (Ziauddin and Sabatini 2001). Conversely, limitations of
TCAs involve essential processes of transfection, such as internalization and subsequent
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expression of DNA. Transfection on microarrays has only been achieved with HEK and
COS cell lines due to the size of the array spot (Bailey, Wu et al. 2002). Thus, new
approaches need to be investigated to increase transfection efficiencies for more cell
types on microarrays. Ziauddin and Sabatini used SMD to transfect hundreds of cells on a
DNA/gelatin printed microarray and discovered gene products that alter cellular
physiology (Ziauddin and Sabatini 2001). Further development of using the SMD
approach in cell arrays requires the investigation of a cost-effective delivery system that
efficiently transfects a wide variety of primary cell lines and provides for spatially
controlled DNA within different domains (Ziauddin and Sabatini 2001; Pannier and Shea
2004). This need indicates exploring different immobilization techniques and materials
for an efficient interaction of the DNA probe with the microarray for improved
performance. Zein, a low-cost and abundant protein from corn, has been shown to
interact with DNA (Regier, Taylor et al. 2012), promote cell proliferation (Sun, Dong et
al. 2005), and has been used as a coating in the food and pharmaceutical industry (Shukla
and Cheryan 2001). Therefore, zein would be a potential candidate for use in microarray
technology to adsorb DNA complexes, support cell adhesion and be fabricated and stored
for future use.

1.5.4 Tissue Engineering
Tissue engineering (TE) is defined as “an interdisciplinary field that applies the principles
of engineering and life sciences towards the development of biological substitutes that
restore, maintain or improve tissue function or a whole organ” (Langer and Vacanti
1993). The integration of gene delivery and structural support in TE scaffolds has the
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potential to greatly enhance tissue repair in the case of injury or disease. The physical
structure of the scaffold allows for the creation and maintenance of space for cell
adhesion and migration and also serves as a depot for sustained gene delivery and
controls the local environment of gene transfer (Agarwal and Mallapragada 2008).
Using this controlled manner of transfection, direction of cell function can be achieved.
TE scaffolds have been formed from both synthetic and natural polymers. Natural
polymers have the advantages of providing innate degradability and bioactivity, (Dang
and Leong 2006; Malafaya, Silva et al. 2007) but typically suffer from low mechanical
stability, limited ability to be processed, and a relatively short release period compared to
synthetic polymers (Panyam and Labhasetwar 2003; Yannas 2004). Natural polymers
such as collagen, gelatin and chitosan have been extensively used as TE scaffolds.
However, these materials are often chemically treated to improve biological stability and
mechanical properties, which can result in future problems. Therefore, new materials
should be investigated for their potential in TE scaffolds and tailored for tissue-specific
considerations.

Another major challenge in the design and engineering of tissue, is the temporal and
spatial combination of signals to produce efficient gene delivery that is required for the
formation of functional tissues (De Laporte and Shea 2007), which is based on the
interaction of the scaffold and vector. DNA incorporated into TE scaffolds can be either
encapsulated in the scaffold material by DNA-loaded microspheres, or blended with the
polymer prior to scaffold formation (Jang, Rives et al. 2005) or immobilized to the
scaffold surface (Jang, Bengali et al. 2006). Jang and Shea formed a TE scaffold through
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the fusion of DNA-loaded PLGA microspheres using a gas foaming and particulate
leaching process, and demonstrated sustained release of DNA but the degradation
products of PLGA negatively affected the stability and integrity of the DNA (Jang and
Shea 2003). Another study showed plasmid encoding vascular endothelial growth factor
(VEGF) incorporated into porous PLGA scaffolds that were subcutaneously implanted
into mice, not only induced transgene expression for 105 days but increased the blood
vessel density and size of vessels at the implantation site (Jang, Rives et al. 2005). The
alternative approach, immobilizing the DNA to the surface of the scaffold after
fabrication, can overcome degradation or deactivation problems associated with the
scaffold processing technique, such as high temperatures and harsh solvents.
Polyethylenimine (PEI)/DNA complexes were immobilized on a PLGA scaffold surface
and in vitro transfection studies employing the surface-immobilized complexes reported
increased number of transfected cells and higher level of gene expression than traditional
bolus delivery, with the use of lower amounts of DNA (Jang, Bengali et al. 2006). These
studies highlight the strategies that are possible for controlled DNA delivery from TE
scaffolds but do not provide an optimal delivery system for guiding tissue formation.
Thus, engineering a controlled and efficient DNA-loaded tissue scaffold is still needed
and new polymers should be explored. Recently, DNA-loaded zein nanoparticles were
formed and demonstrated stability of the DNA encapsulated and released from zein
particles (Regier, Taylor et al. 2012), indicating their potential use in fabrication of TE
scaffolds for sustained gene delivery and improved performance of tissue engineering
constructs (Shea, Smiley et al. 1999). These DNA-loaded zein nanoparticles were further
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investigated in Chapter 2 of this thesis for resistance to DNase degradation,
cytocompatibilty and cellular internalization for gene delivery applications.

1.5.5 Drug-Eluting Biomedical Devices
Controlled delivery of therapeutic agents from biomedical devices can improve their
safety and efficacy in vivo by reducing the foreign body response of the host, such as
infiltration of inflammatory cells and development of a dense layer of fibrotic connective
tissue (Anderson 2001). This dense layer of tissue shields the biomedical device from the
immune system and isolates it from the surrounding tissues (Rolfe, Mooney et al. 2011).
Numerous biomedical devices that incorporate drug delivery including vascular stents
and wound dressings (Zilberman, Kraitzer et al. 2010), will be discussed in more detail
below as both stand to benefit the most from incorporation of gene delivery.

Drugs are typically released from medical devices through surface coatings of a
continuous film or a film of nanoparticles encapsulating the drug (Lo, Van Tassel et al.
2010). Biocompatible coatings are used due to their ability to mask the underlying
surface of the implanted biomedical device by producing a hydrophilic interface between
the device surface and the tissue fluids, which minimizes tissue reactions induced by
device implantation (Göpferich 1996). The incorporation of drugs within the coating
improves the device/host tissue interactions (Morais, Papadimitrakopoulos et al. 2010), as
seen with drug eluting vascular stents and wound dressings (Zilberman, Kraitzer et al.
2010).

21

1.5.5.1 Drug-eluting stents
Coronary artery disease (CAD), the narrowing of the arteries of the heart, is the most
common cause of death in the world (Hoyert DL 2012). The technique of balloon
angioplasty, the augmentation of the artery with the use of a stent, was a great milestone
to combat this disease, but the re-narrowing of arteries, known as restenosis, was seen in
30-60% of patients within 6 months of surgery (Holmes, Vlietstra et al. 1984; Fischman,
Leon et al. 1994; Serruys, de Jaegere et al. 1994). This high percentage of restenosis led
to the development of drug-eluting stents (DESs), where drugs that inhibit platelet
activation, acute inflammation, smooth muscle cell proliferation, extracellular matrix
production, angiogenesis, and vascular remodeling (Sousa, Serruys et al. 2003) are
incorporated onto the surface of the stent, by covalently attaching the drug (Joung, Kim et
al. 2003) or infusing the drug into a polymer coating (Holmes Jr, Camrud et al. 1994).
Currently, there are a few commercial DESs on the market, but a drawback of DESs is an
increased rate of myocardial infarction (MI) due to late stent thrombosis (Camenzind
2006; Aziz, Morris et al. 2007; Camenzind, Steg et al. 2007). Thus, there still remains a
need to investigate delivery of therapeutic compounds from stents.

Recent investigation of the incorporation of DNA onto stents has become the forefront of
the field as local delivery of DNA allows for smaller, more efficient and prolonged dose
of therapeutic agents (i.e. genes) as compared to the transient delivery of drugs
(Takahashi, Letourneur et al. 2007; Ganly, Hynes et al. 2013). Early work of gene-eluting
stents (GESs) used polymer coatings with viral vectors and showed limited success in
animal studies with both reporter and therapeutic gene delivery (Fishbein, Alferiev et al.
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2006). Both the polymer coating and gene vector have been explored to improve
efficiency of the gene-eluting stents in reducing restenosis, inflammation and late
thrombosis (Takahashi, Letourneur et al. 2007). The majority of these studies have used
viral vectors because of their high intrinsic transfection efficiency. Ye et al reported the
use of adenovirus encoding β-galactosidase using a polyactide/polycaprolactone coating
for stent-based delivery (Ye, Landau et al. 1998). Adenoviruses have also successfully
delivered a green fluorescent protein (GFP) as a reporter gene, and a tissue inhibitor of
metalloproteinase (TIMP) as a therapeutic gene against restenosis, from collagen-coated
stents and phosphorylocholic (PC)-coated- stents, respectively (Klugherz, Song et al.
2002; Johnson, Wu et al. 2005).

However, due to the safety and technical concerns discussed with use of viral vectors
above, recent studies have focused on using nonviral vectors for GESs. For example,
lipo(poly)plex-based gene delivery from PLGA/gelatin-coated meshes has been reported
in a rabbit iliac artery restenosis model with substantial GFP expression at early time
points; however, limitations were encountered due to rapid dissolution of the coatings in
vivo (Brito, Chandrasekhar et al. 2010). Overall, the level of transfection achieved with
nonviral vectors remains low in GESs (Leclerc, Gal et al. 1992), and some polymer
coatings to deliver the DNA have shown to be problematic because of harmful properties
of the polymer coatings, such as the degradation products of poly(lactide-co-glycolide)
(PLGA) (vanderGiessen, Lincoff et al. 1996; Carter, Aggarwal et al. 2004). Thus, there is
a need for investigating new polymeric coating materials with the ability to support
delivery of nonviral gene vectors to improve efficacy of GESs. In this thesis, zein was
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studied as a potential surface coating material for substrate-mediated gene delivery, with
potential application in GESs.

1.5.5.2 Wound dressings
Wound dressings are another type of drug-eluting medical devices that have great
potential in medicine, in particular for revolutionizing treatment of wounds including
burns, diabetic ulcer and pressure sores, are drug-eluting wound dressings. In all of these
types of wounds, skin is damaged, which is an important organ for serving as a physical
barrier for infections, providing sensation, regulating temperature and managing
excretion of waste, salt and sweat (Proksch, Brandner et al. 2008). The major
complication in healing wounds is infection, which has been estimated to cause 75% of
the mortality following burn injuries (Revathi, Puri et al. 1998). In contrast to drugeluting stents that deliver anti-proliferative agents, wound dressings are loaded with
antibacterial agents and growth factors to reduce bacterial infection and promote healing,
respectively. Antibacterial agents are highly water-soluble and thus fast release from the
dressing is a major issue and must be addressed to improve the performance of the
dressing (Zilberman, Kraitzer et al. 2010). Along with reducing infiltration of bacteria,
promoting new tissue growth is essential to successful wound healing and involves a
cascade of sequential but overlapping molecular and cellular events including
inflammatory response, re-epithelialization, granulation tissue phase and finally
remodeling of the healed wound (Andreadis and Geer 2006). This complex process is
difficult to emulate, with most research focusing on different biomaterials and therapeutic
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molecules to achieve successful wound healing by inhibiting infection and
simultaneously promoting tissue growth (Andreadis and Geer 2006).

For wound healing, biomaterials must possess enough elasticity to conform to the size
and shape of the wound, endow temporary mechanical support to withstand in vivo
forces, provide some level of bioactivity to accommodate cellular attachment and
migration, act as reservoirs for the controlled delivery of wound healing factors, and,
finally, should be non-immunogenic and absorbed by the body once tissue regeneration is
complete (Andreadis and Geer 2006). Natural and synthetic biomaterials have been used
in wound healing such as collagen and PLGA, respectively (Ishikawa, Terai et al. 2003;
Said, El-Halfawy et al. 2012). For synthetic biomaterials, a significant limitation is the
need to change dressings throughout the wound healing process, which could increase the
likelihood of infection in addition to causing unnecessary pain. This drawback leads to
the investigation of natural biomaterials for wound healing due to innate biocompatibility
and degradability with collagen being the most commonly used natural material.
However, despite its limited success in wound healing, collagen is susceptible to rapid
biodegradation and to bacterial invasion (Sela, Kohavi et al. 2003). Therefore, there is a
need to investigate new biomaterials that can improve the efficiency of wound healing.

Administration of antibacterial agents and growth factors has shown success in wound
healing applications. Nevertheless, the lack of efficient delivery of growth factors is due
to the short half-lives and susceptibility from harsh proteolytic environments (Lee, Silva
et al. 2011). Thus, gene delivery has recently been explored as an alternative to growth
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factor delivery since infiltrating cells internalize the genes and produce the therapeutic
protein(s) in the local environment continuously. For example, collagen dressings
embedded with DNA encoding for platelet-derived growth factor (PDGF-A or - B) was
shown to increase granulation tissue, re-epithelialization and wound closure in an
ischemic rabbit ear model (Tyrone, Mogford et al. 2000). Poly(lactide-co-glycolide)
(PLGA) matrices loaded with DNA encoding PDGF were implanted subcutaneously in
Lewis rats, and resulted in significantly increased vascularization and granulation tissue
formation up to four weeks (Shea, Smiley et al. 1999). However, with the use of nonviral
delivery systems, the DNA transfer efficacy in these previous studies were too low for
translation to the clinic and thus new delivery systems along with new biomaterials need
to be investigated for controlled released of DNA and promotion of tissue growth for
optimal wound healing. Due to zein’s ability to form films composed of nanospheres with
properties that would be beneficial to wound healing, such as resistance to microbial
attack, flexibility and capability of sustained DNA release from zein spheres, make it a
promising candidate for wound dressings (Shukla and Cheryan 2001; Zhong, Jin et al.
2009; Gong, Sun et al. 2011). In this thesis, zein, a hydrophobic protein from corn, was
used to form a film for substrate-mediated gene delivery for potential application in geneeluting biomedical devices.

1.6 Zein: General Information
A major objective of this thesis is to investigate a new biomaterial, zein, for its ability to
be used in gene delivery strategies for applications in gene therapy, DNA vaccination,
functional genomics and diagnostics, and biomedical devices. Zein, the major storage
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protein from corn, was first isolated in 1821 by John Gorham and first extracted in 1902
by Osborne (Osborne 1891; Lawton 2002; Anderson and Lamsal 2011). The majority of
zein is found in the endosperm of the corn kernel and contributes to the hardness of the
endosperm (Shukla, Cheryan et al. 2000; Anderson and Lamsal 2011). Since zein is a
natural protein, it is heterogeneous in makeup and is actually a mixture of different
peptides of various molecular weights (Mw) and solubility (Pomes 1971; Esen 1987;
Lawton 2002; Anderson and Lamsal 2011). There have been numerous systems of
nomenclature identifying zein fractions but the classifications proposed by Esen have
become the standard for understanding the various polypeptides. Esen fractionated whole
zein into three main fractions of zein, α, β and γ, determined by their molecular weight
and solubility in isopropyl alcohol (IPA). The major fraction, α-zein, accounts for 7585% of total zein content and is soluble in 50-95% IPA, with a Mw of 21-25 kDa and
10kDa. β-zein (Mw of 17-18 kDa) accounts for 10-15% of total zein content and is
soluble in 30-95% IPA with a reducing agent. γ-zein (Mw of 27 kDa) accounts for 5-10%
of zein content and is soluble in 0-80% IPA with addition of a reducing agent (Esen
1987).

Zein is an amphiphilic protein, possessing both hydrophobic and hydrophilic properties,
with more than 50% of its 225 amino acid residues (Geraghty, Peifer et al. 1981) being
hydrophobic (Cabra, Arregun et al. 2005), including high percentages of leucine (20%),
proline (10%) and alanine (10%), but zein also has a high glutamine (hydrophilic) content
(21-26%) (Pomes 1971; Padua Graciela and Wang 2009). Zein’s solubility is attributed to
its amino acid composition and therefore due to the high content of nonpolar amino acid
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residues, zein is insoluble in water and alcohol but soluble in an aqueous alcohol solution.
Also, due to its deficiency in the essential amino acids, lysine and tryptophan, zein is of
poor nutritional quality. (Pomes 1971).
The molecular structure of zein is controversial due to the presence of different fractions.
However, a structural model of zein in 70% methanol from CD spectra was proposed in
1982 by Argos et al. as a helical wheel with nine homologous repeating units arranged in
an anti-parallel form stabilized by hydrogen bonds resulting in a slight aysmetric protein
structure (Argos, Pedersen et al. 1982). Later, Matsushima updated the model through
data obtained by X-ray scattering, stating that α-zein exists as asymmetric particles of 13
nm in length, had an elongated molecular structure (axial ratio of 6:1) and the helices,
which make up 50-60% of zein’s molecular structure, were connected at each end by
glutamine bridges as seen in Figure 1-2 (Matsushima, Danno et al. 1997). This new
model leads to the understanding of zein being amphiphilic, with a hydrophobic outer
surface and hydrophilic top and bottom surfaces containing the glutamine- rich bridges
(Wang and Padua 2012).

Figure 1-2. A possible structural model for α-zeins (Z22). Each of the tandem repeat
units formed by a single α-helix is presented by the cylinder and glutamine-rich `turns' or
loops joining them by the curve. The anti-parallel helices of tandem repeats stack linearly
in the direction perpendicular to the helical axis (the c-axis) (Reprinted from Matsushima,
Danno et al. 1997).

28

With its amphiphilic character (Wang, Wang et al. 2004), the hydrophobic regions of zein
can cause aggregation into colloidal particles, and the polar side chains allow for
interaction with drugs or molecules to be encapsulated, including DNA as presented in
Chapter 2 of this thesis. Also due to zein’s amphiphilicity, it has the ability to selfassemble into a film through a mechanism known as evaporation-induced self-assembly
(EISA). This mechanism is a process that involves the preferential evaporation of one of
the solvents of a binary or tertiary solvent, causing a polarity change in the solution,
which drives the self-assembly of zein (Wang and Padua 2010; Wang and Padua 2012).
Zein films formed using EISA are presented in Chapter 3 of this Thesis.

Since the isolation of zein in 1821, it has been extensively researched due to its natural
film-forming and solubility properties. Goldsmith was one of the first to promote the use
of zein. He demonstrated that mixing zein with formaldehyde could produce a tougher
and more stable composite for possible use as a plastic substitute (Lawton 2002).
However, it was not until the mid-1930’s that the use of zein expanded in research, which
may be due to the start of operation of a commercial zein plant in 1938 (Lawton 2002;
Anderson and Lamsal 2011). Today, zein is used in numerous industrial and consumer
applications, described below, and suggest its potential for use in biomedical
applications, including gene delivery systems.

1.6.1 Zein Films & Scaffolds
As described above, zein can form films, with a smooth or particle comprised surface,
using simple fabrication techniques, and thus the first major commercial uses of zein
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involved the coating of various objects during World War II (Lawton 2002). Zein films
are tough, glossy, hydrophobic, greaseproof, biodegradable and resistant to microbial
attack (Shukla and Cheryan 2001). These unique properties of zein led to its use as a
protective coating for: floors for steamship engine rooms, carton stocks of doughnuts,
crackers, cookies, and paper that wrapped airplane and machine parts for shipment
(Lawton 2002). However, the use of zein for grease-proofing died out by 1954, but this
did not stop exploration of zein’s potential in other areas, such as food and
pharmaceutical industries.

The food industry first utilized zein as a protective coating on fortified rice in 1955
(Mickus 1955). This application opened the door for zein films to be used for preserving
edible products due to its biodegradability, water-resistance and excellent gas barrier
(Lawton 2002). Zein has been used to coat nuts to protect against rancidity and
demonstrated increased storage time (Cosler 1958). Tomatoes coated with zein showed
delayed color change, maintained firmness, and extended shelf-life by 6 days (Park,
Chinnan et al. 1994).

By the mid-1950s, the pharmaceutical industry started using zein instead of sugar for
tablet coating (Winters and Deardorff 1958). Using zein to coat tablets instead of sugar
allowed for quicker coating procedures, resistance to heat, abrasion and humidity as well
as the ability to conceal taste and odors of original tablets (Winters and Deardorff 1958;
Lawton 2002). More recently, zein has been investigated for its potential in controlled
release applications in the pharmaceutical industry (Shukla and Cheryan 2001). Due to its
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water insolubility, zein allows for the sustained release of cargo (Hurtado-Lopez and
Murdan 2006). Rosenthal was the first to claim sustained release using zein as a matrix
polymer with the drug dispersed throughout to extrude pellets for tableting (Fritz 1959).
O’Donnell et al. retarded the release of acetaminophen tablets by the application of an
aqueous pseudolatex of zein (O'Donnell, Wu et al. 1997). Zein served as the coating for
pectin hydrogel beads for drug delivery to the colon, since pectin remains intact in the
upper GI tract and is degraded specifically in colon. The zein coating increased the water
resistance of the pectin beads as well as protected the drug from the acidic environment
of the stomach (Liu, Fishman et al. 2006).

Other studies on zein films suggest its potential use for SMD. Patterned hydrophobic and
hydrophilic zein films were formed by adsorbing zein on different hydrophilic and
hydrophobic surfaces. Spatial distribution of cells was confined to the areas of zein
adsorbed on hydrophilic surfaces. This study suggests that zein could be used to control
spatial growth of cells (Wang, Xian et al. 2008) for applications in tissue engineering or
transfected cells arrays. Zein films composed of microspheres have been investigated as a
drug-eluting coating implanted devices. Controllable heparin- loaded zein films produced
superior anticoagulation and inhibited of platelet adhesion for application in
cardiovascular devices, such as a stent (Wang, Lin et al. 2005). Zein microspheres
displayed sustained release of ciprofloxacin, an antibiotic, for the prevention of bacterial
infection, which could have potential in wound healing applications (Fu, Wang et al.
2009). The wide use and success of zein films suggests its potential in SMD for gene
delivery applications.
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The success of zein films in sustained delivery of an active compound has led to the
investigation of zein use in tissue engineering applications. Jin-Ye Wang and colleagues
evaluated the surface morphology and biocompatibility of two different methods of
preparing zein films, using HL-7702 liver cells and NIH3T3 mouse fibroblast cells
(Dong, Sun et al. 2004). The two zein films were comprised of particles and differed by
particle sizes ranging from 100-500 to 500-2500nm. The film composed of smaller
particles at the lowest concentration showed the best proliferation of cells. Wang and
colleagues also measured the degradation of zein films by trypsin and collagenase and
showed that the resulting degradation products of zein can enhance cell viability at
certain concentrations (Sun, Dong et al. 2005). These studies established the
biocompatibility and degradation of zein films for in vitro studies (Sun, Dong et al. 2005)
but also paved the way for the use of zein in tissue engineering and gene delivery
applications. Further investigation of zein scaffolds for possible bone substitute implants
demonstrated adequate mechanical properties including a Young’s modulus of 28-87
MPa and compressive strength of 1.5-11.8 MPa, which is comparable to cancellous bone
(Gong, Wang et al. 2006). Mesenchymal stem cells (MSC) displayed good adhesion,
proliferation and differentiation into osteoblasts on the porous zein scaffolds in the
presence of dexamethasone (Gong, Wang et al. 2006). Wang also demonstrated that the
mechanical properties (tensile and flexural) of the porous zein scaffold could be
improved by the addition of the fatty acid, oleic acid (Wang, Gong et al. 2007). These
findings add to the already many unique properties of zein and strengthens its use in not
only tissue engineering but other medical applications, including gene delivery.
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1.6.2 Zein Nano- and Microspheres
In addition to films, zein has been used as particulates encapsulating molecules for
sustained release and zein particles are most commonly formed by phase separation, also
known as coacervation, which is the separation of colloidal systems into two liquid
phases (Gander, Blanco-Príeto et al.). Zein particles formed by coacervation have been
used for a variety of molecules for a wide range of applications. For example, zein
microspheres encapsulating abamectin, a natural pesticide that degrades rapidly in air and
sunlight, was shown to have enhanced photostability when encapsulated in zein
microspheres (Demchak and Dybas 1997).

Furthermore, the success of zein to provide sustained release has translated to its use in
drug delivery. Zein microspheres encapsulating ivermectin, an agent used to destroy
parasites, were used for oral and subcutaneous administration in dogs to protect against
parasites (Liu, Sun et al. 2005; Gong, Sun et al. 2011). Biocompatible fluorescent zein
nanoparticles were also synthesized for simultaneous bioimaging and drug delivery of 5fluoroacil (5-FU). This study displayed good biocompatibility of nanoparticles with L929
and MCF-7 cell lines even at high concentrations (Ravindran Girija, Balasubramanian et
al. 2012). Zein microspheres have also been used as carriers for antigens, such as
ovalbumin, to be delivered orally, intramuscularly and vaginally (Hurtado-Lopez and
Murdan 2005). Zein microspheres demonstrated sustained release of Gitoxin, a
cardiotonic glycoside used for treating cardiac arrhythmia, and were effective in
suppressing platelet adhesion (Muthuselvi and Dhathathreyan 2006). Hollow zein
nanoparticles loaded with metformin, an anti-diabetic drug, displayed high loading
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capacity, sustained and controlled release, and cellular internalization within an hour of
incubation (Xu, Jiang et al. 2011). Recently in our lab, zein has been used to encapsulate
DNA and demonstrated plasmid integrity during the fabrication process, high loading and
encapsulation, and sustained release (Regier 2011; Regier, Taylor et al. 2012). These
studies demonstrate zein’s potential in providing sustained and effective release of the
encapsulated compound for the intended application. The DNA-loaded zein spheres
previously formed in our lab were further investigated in Chapter 2 of this thesis for
applications in oral and intramuscular gene delivery.

1.7 Objective of thesis
The objective of this thesis was to investigate the potential of zein as a carrier for DNA,
in both nanosphere and film form, to improve gene delivery strategies. Chapter 2
discusses the development of zein nanospheres encapsulating DNA, with demonstrated
ability to resist DNase degradation, promote cellular internalization and robust
biocompatibility. Chapter 3 describes preliminary studies on the fabrication of zein films
for SMD of DNA. Finally, Chapter 4 presents future directions for zein nanosphere and
films in the realm of gene delivery.
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CHAPTER 2: DNA-loaded Zein Nanospheres
2.1 Background
Gene delivery, the introduction of exogenous DNA into cells with subsequent expression,
is applicable to the fields of gene therapy (Niidome and Huang 2002), DNA vaccination
(Donnelly, Ulmer et al. 1997) functional genomics and diagnostics (Pannier, Ariazi et al.
2007), tissue engineering (Shea, Smiley et al. 1999), and drug-eluting medical implants
(Zilberman, Kraitzer et al. 2010). Because of the technical and safety issues associated
with viral gene delivery, the use of plasmid DNA, which has lower immunogenicity,
more flexibility in transgene capacity, and potential for industrial production, is an
appealing alternative for gene transfer (Mintzer and Simanek 2009). Delivery of DNA
can result in the expression of a therapeutic gene or induction of protective immunity
(Donnelly, Ulmer et al. 1997; Li and Huang 2000). Although the injection of naked
DNA can lead to transgene expression, the level and localization of expression are
limited by rapid degradation by nucleases in the serum and clearance by the mononuclear
phagocyte system (Niidome and Huang 2002). Encapsulation of DNA has the potential
to improve in vivo response and transfection by shielding the CpG methylation patterns
of DNA from the immune system, shielding the plasmid from degradation by enzymes
and low pH, increasing residence time, and providing a controlled release (Agarwal and
Mallapragada 2008). Nano- and microspheres incorporating DNA, which administer
DNA in a controlled, sustained, and localized/targeted manner through the use of
polymer systems that entrap DNA and release it through hydrolytic or enzymatic
mechanisms, have been applied to gene therapy, DNA vaccination, and tissue
engineering (Panyam and Labhasetwar 2003; Agarwal and Mallapragada 2008).
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For gene therapy and DNA vaccination applications, several routes of administration for
DNA delivery systems are possible, including oral delivery and intramuscular injection.
The oral route is perhaps the most appealing, due to its associated high patient
compliance and convenience. The oral route has the additional advantages of presenting
a large surface area of intestinal epithelium for transfection and allowing treatment of
regional disorders by providing access to the luminal side of the intestine (Bhavsar and
Amiji 2007). Oral gene delivery has the potential to treat diseases associated with the
gastro-intestinal tract (GI-tract) (Page and Cudmore 2001) as well as systemic diseases
(Rothman, Tseng et al. 2005), and can provide for systemic and mucosal immunity
(Jones, Corris et al. 1997). However, oral delivery of DNA is complicated by low pH in
the stomach and DNases in the GI-tract (Loretz, Foger et al. 2006), which degrade
unprotected DNA. Particulates are considered a viable tool for the protection of DNA
from the harsh environment of the stomach and intestine (Chen and Langer 1998).
Previous studies have focused on poly(lactide-co-glycolide) (PLGA) and chitosan to form
DNA-loaded nano- and microspheres for oral gene delivery (Jones, Clegg et al. 1998;
Roy, Mao et al. 1999; Agarwal and Mallapragada 2008; Bowman, Sarkar et al. 2008).
While these delivery vehicles have been shown to elicit the production of a therapeutic or
immune response inducing protein, the level of protein produced is often modest with
high variability (He, Wang et al. 2005; Bowman, Sarkar et al. 2008). Furthermore,
although these materials have provided a valuable proof of concept, their lack of
sufficient efficacy suggests that new polymers need to be investigated.
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The oral route of administration is not the only route of interest for gene therapy and
DNA vaccination. The direct injection of DNA delivery systems into muscle has been
investigated for DNA vaccination (O'Hagan and Rappuoli 2004) and gene therapy
(Tripathy, Svensson et al. 1996). Injection of DNA-loaded nanoparticles and
microparticles into muscle primarily results in local transfection because the particles do
not readily diffuse from the tissue. Transfection of muscle cells can elicit an immune
response (O'Hagan and Rappuoli 2004), can result in a physiological change in the
injected muscle (Shyu, Manor et al. 1998), or can serve as a depot releasing the encoded
protein into circulation (Tripathy, Svensson et al. 1996). Particulate DNA delivery
vehicles have been shown to increase the magnitude and duration of transgene expression
compared to other delivery vehicles or naked DNA administered intramuscularly (Wang,
Zhang et al. 2002; Agarwal and Mallapragada 2008). However, as for oral delivery of
DNA-loaded particulates, lack of sufficient efficacy with intramuscular administration
suggests that new polymers need to be investigated for DNA delivery.

Natural polymers have been applied to drug and gene delivery and tissue engineering
applications, and have the advantages of providing innate degradability and bioactivity
(Dang and Leong 2006; Malafaya, Silva et al. 2007), but typically suffer from low
mechanical stability, limited ability to be processed, and a relatively short release period
compared to synthetic polymers (Panyam and Labhasetwar 2003; Yannas 2004). Zein,
the prolamin or storage protein from corn, has properties that make it a promising
candidate material for particulate delivery. Zein is composed of three fractions, which
are defined by their molecular weight and solubility, including α (75-85% of total zein,
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21-25 kDa and 10 kDa), β (10-15% of total zein , 17-18 kDa), and γ (5-10% of total zein,
27 kDa) zein (Esen 1987). More than 50% of the 225 amino acid residues (Geraghty,
Peifer et al. 1981) of zein are hydrophobic (Cabra, Arregun et al. 2005), including high
percentages of leucine, proline, and alanine, which renders it insoluble under
physiological conditions and capable of sustained release of encapsulated compounds
(Hurtado-Lopez and Murdan 2006). Zein also has a high glutamine content (Pomes
1971; Padua Graciela and Wang 2009), contributing polar, protonable side chains. With
its amphiphilic character (Wang, Wang et al. 2004), the hydrophobic regions of zein can
cause aggregation into colloidal particles, and the polar side chains allow for interaction
with DNA. The surface charge of zein varies with the pH of the environment (Deo,
Jockusch et al. 2003), with an isoelectric point of α-zein at pH 6.8 (Cabra, Arregun et al.
2005). Degradation of zein occurs very slowly by hydrolysis but is accelerated by the
action of enzymes (Hurtado-Lopez and Murdan 2006) and has been shown to be
especially well-suited for oral delivery (DiBiase and Morrel 1997; Parris, Cooke et al.
2005; Gong, Sun et al. 2011) Zein has been shown to be biocompatible and to have
degradation products that can enhance cell proliferation (Sun, Dong et al. 2005).

Nano- and microspheres composed of zein can be fabricated using a simple coacervation
technique, which involves no harsh solvents or high temperatures. Zein microparticles
have successfully been used to orally deliver ivermectin in a canine model (Gong, Sun et
al. 2011) and desmopressin in a Phase I clinical trial (DiBiase and Morrel 1997).
However, to the best of our knowledge, there have been no reports on the fabrication of
zein nanospheres encapsulating a large, charged and hydrophilic molecule, like DNA.
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Due to the promise of this natural biomaterial for drug delivery, including its
biocompatibility, promotion of cell proliferation, capability for sustained release,
interaction with cell membranes and its versatility to interact, encapsulate and protect
cargo, zein has recently been investigated as a particulate DNA delivery system.

Previous work in the Pannier Laboratory has shown zein’s ability to form DNA- loaded
nanospheres, prepared using a coacervation process that was capable of preserving the
DNA during the encapsulation process and resulted in DNA loading maximized at 6.1 ±
0.2 mg DNA/g zein (Regier 2011; Regier, Taylor et al. 2012), which is comparable to
that achieved by most PLGA particulates (Astete and Sabliov 2006). In addition, the
fabrication technique allowed for the capability of controlling the size of spheres via the
zein to DNA ratio; sphere sizes ranged from 157.8 ± 3.9 nm to 396.8 ± 16.1 nm.
Optimized spheres (80:1 zein to DNA ratio) demonstrated adequate stability in water and
PBS and had a sustained release of DNA in PBS over a period of seven days. This work
laid the foundation for the potential of zein to be used as a natural polymer for particulate
gene delivery. However, the potential of these zein/DNA nanospheres to protect their
DNA cargo from DNA nucleases found throughout the body, as well as the interactions
of these DNA-loaded zein spheres with cells, remained uncharacterized. Therefore, the
objective of this study was to investigate the ability of DNA-loaded zein nanospheres to
resist DNase degradation and characterize cellular internalization of the spheres and
cytotoxicity, to more fully demonstrate zein’s potential in future clinical applications of
gene delivery.
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2.2. Materials and Methods
2.2.1 Plasmid preparation
All experiments used pDsRed2-N1 (Clontech, Mountain View, CA), a plasmid encoding
for the red fluorescent protein, DsRed2. The plasmid was purified from bacteria culture
using Qiagen (Valencia, CA) reagents and stored in Tris-EDTA (TE) buffer solution
(10mM Tris, 1mM EDTA, pH 7.4) at -20°C. Only plasmids with purity of 1.8 or better
measured by 260/280 ratio (Nanodrop 2000 Spectrophotometer, Thermo Scientific,
Waltham, MA) were used.

2.2.2 Sphere preparation
Zein spheres were formed by the coacervation technique. Zein (Freeman Industries LLC,
Tuckahoe, New York) was first dissolved in 70% ethanol at pH 3 (pH adjusted with 1M
hydrochloric acid) forming a 1% w/v zein solution. Subsequently, 1 mL of 100% ethanol
pH 3 was added to 1 mL of the 1% zein solution. A total of 1 mL of DsRed2 plasmid
DNA (1 mg/mL in TE buffer) and TE buffer were added, followed by the dropwise
addition of 10mL ddH2O (18.2 mΩ-cm) while vortexing. Spheres were formed by
coacervation during the addition of the ddH2O. The zein to DNA ratio was determined by
the amount of DNA solution added and ranged from 20:1 to 250:1. Blank spheres were
formed without DNA (TE buffer substituted for DNA solution). The pH of the resultant
sphere suspension was increased to 10 by the addition of 1M NaOH so that the spheres
could be resuspended, as this pH induced sufficient surface charge on the spheres to
prevent aggregation during centrifugation (Demetriades, Coupland et al. 1997; Gan,
Wang et al. 2005; Lai and Guo 2011). Spheres were then pelleted by centrifugation at

40

10,000 g for 1 hour at room temperature. The supernatant was removed and spheres were
resuspended in ddH2O.

2.2.3 DNA integrity
DNA was extracted from 80:1 zein:DNA ratio spheres using a standard
phenol/chloroform extraction followed by gel electrophoresis. After sphere preparation
and centrifugation, the supernatant was removed to a separate conical tube and pelleted
spheres were resuspended in 5 mL ddH2O. An equal volume of
phenol/chloroform/isoamyl alcohol 25:24:1 (Fisher BioReagents, Fair Lawn, NJ) was
added to both the sphere and the supernatant solutions and these solutions were vortexed.
The solutions were centrifuged at 10,000 g for 15 minutes at 4°C and then the top,
aqueous layer was removed to separate tubes, to which 0.5 volume of chloroform (Fisher
Chemical, Fair Lawn, NJ) was added, followed by vortexing. Solutions were again
centrifuged at 10,000 g for 15 minutes at 4°C and the top, aqueous layer was then
removed to separate tubes, which were centrifuged at 10,000 g for 15 minutes at 4°C to
separate any residual chloroform from the aqueous layer. Any organic layer present was
removed from the bottom of the tubes. The volumes of the aqueous DNA solutions were
measured and were used for gel electrophoresis, as described below.

For PBS release study, pelleted spheres were resuspended in 2 mL ddH2O and DNA
release from spheres into 1X PBS was measured over 7 days. Separate samples for each
time point were prepared by diluting 150 μL of sphere suspension (containing
approximately 750 g of zein and 4.3 g of DNA) in 3 mL of PBS. These samples were
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incubated in a humidified 37°C chamber for varying times. At predetermined time
points, an entire sample was removed from the incubator and spheres were separated
from the supernatant by centrifugation. The spheres and the supernatant were extracted
with phenol/chloroform, as described above, and DNA was analyzed through gel
electrophoresis.

Sphere extraction solutions and release samples (as described above) were analyzed for
plasmid integrity, as was the ability of the spheres to protect encapsulated DNA from
endonucleases. For the latter, naked DNA (10 μg) and optimized 80:1 zein/DNA spheres
(equivalent to 10 μg of DNA) were treated with 7.5 U of DNase I (Promega, Madison,
WI) and incubated for 15 min at 37°C. The reaction was stopped by adding 50 mM
Ethylenediaminetetraacetic acid (EDTA) and incubating at 65°C for 10 min. The integrity
of the DNA in the sphere extraction solutions, release samples and DNaseI degradation
study was all analyzed by agarose (1%) gel electrophoresis. DNA was detected using
ethidium bromide (Fisher BioReagents). A Kodak gel documentation system (EDAS
290, Kodak, Rochester, NY) was used to capture digital images of the gels.

2.2.4

Cellular response

2.2.4.1 Cell culture
Human embryonic epithelial kidney cells, HEK 293T (ATCC, Manassas, VA), were
cultured in T-75 flasks in Dulbecco’s modified Eagle’s medium (DMEM,
Gibco/Invitrogen, Carlsbad, CA) containing 4.5 g/L glucose and supplemented with 10%
fetal bovine serum (FBS, Gibco), 2 mM L-glutamine (Gibco), and 1%
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penicillin/streptomycin (Gibco). For seeding, cells were counted using a hemocytometer
and trypan blue staining for viable cells after being dissociated with 1mM EDTA. Human
colon carcinoma cells, Caco-2, were obtained from ATCC and were cultured in T-75
flasks in Eagle’s minimum essential medium (EMEM, ATCC) supplemented with 20%
FBS (Gibco) and 1% penicillin/streptomycin (Gibco). For seeding, cells were dissociated
with 0.05% trypsin/EDTA (Gibco). For both cell lines, cells were seeded into 48-well
plates or 8-well Nunc Lab-Tek chambered coverglass slides (Thermo Scientific) at a
density of 30,000-33,000 cells per well for HEK 293-T cells and 25,000 cells per well for
Caco-2 cells.

2.2.4.2 Cytotoxicity
Cytotoxicity was assessed using a Water Soluble Tetrazolium (WST-1) salts cell
proliferation assay kit (Roche, Indianapolis, IN). For the WST-1 assay, nanospheres
containing 0.1, 0.25, 0.5, 1.0 or 2.0 μg of DNA were formed at a zein to DNA ratio of
80:1, resuspended in 1 mL ddH2O, and then diluted in OptiMem (Gibco) to a final
volume of 75 μL. Cells were seeded in 48-well plates as described above and after 24
hours of culture, zein/DNA nanospheres were added to the culture media in triplicate
wells. Cells were imaged to observe cell morphology (Leica DMI 3000B, Bannockburn,
IL) and the WST-1 assay was conducted according to the manufacturer’s protocol at 24,
48, and 72 hours after the addition of zein nanospheres. Briefly, cells were washed with
PBS, and incubated at 37°C with the WST-1 solution (10 vol.% WST-1 reagent in
phenol-free DMEM, 400 μl /well). After incubation for 3 hours, absorbance values of
WST-1 solution (100 μl from each well) were measured on an Epoch Microplate
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spectrophotometer (BioTek, Winooski, VT) at a wavelength of 430 nm. Assays were
performed in triplicate on duplicate days.

2.2.4.3 Confocal microscopy
To verify that confocal microscopy could be used to image zein/DNA nanospheres
without labeling, the autofluorescence of zein was investigated (Regier 2011). The
autofluorescence of various zein concentrations in 70% ethanol was measured in a
fluorometer with ultraviolet and blue modules. Once autofluorescence was confirmed
(Regier 2011), confocal microscopy was used to assess cellular morphology in response
to the zein nanospheres, as well as to analyze cellular association of the spheres. Caco-2
and HEK 293T cells cultured with 80:1 or 250:1 nanospheres were imaged using a
confocal microscope (Olympus IX 81, Olympus, Center Valley, PA). Cells were seeded
as described above into 8-well coverslides. Zein spheres were visualized with an
excitation wavelength of (405 nm) and an emission wavelength of (590 nm) and these
images were overlaid with corresponding phase images.

2.2.4.4 Sphere internalization
To assess internalization of zein nanospheres, Caco-2 cells were seeded onto 8-well
coverslides described above and after 36 hours of culture, media was replaced and
zein/DNA nanospheres containing 0.1 g DNA at a zein to DNA ratio of 80:1 were
added to the fresh culture media. Twelve hours after the media change and addition of
spheres, the cells were washed and then membranes were stained using Vybrant DiO celllabeling solution (Molecular Probes/Life Technologies, Carlsbad, CA) for 25 minutes at
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37 C according to the manufacturer’s protocol. Cells were then washed with PBS and
fixed with 10% buffered formalin for 10 minutes. Following staining, confocal
microscopy was performed, with zein and DiO sequentially excited using dual excitation
of 405 and 543 nm for zein and 488 nm for DiO. A series of 15 optical sections in the Zplane were acquired at intervals of 1 m for at least two different locations per well and
images were processed using Olympus FluoView software (v.5.0) to determine location
of the spheres relative to cellular membranes.

2.2.5 Statistics
All experiments were performed between three and six times (noted in figure legends).
Comparative analyses were completed using a student’s t-test or one-way ANOVA
followed by Tukey’s multiple comparison test for multiple data points, both at a 95%
confidence level using Prism software (GraphPad Prism 5, LaJolla, CA). Mean values
with standard error of the mean are reported for all data.

2.3 Results & Discussion
Previously, it was shown that DNA-loaded zein spheres, formed via a coacervation
technique, demonstrated tunable sizes that ranged from 157.8 ± 3.9 nm to 396.8 ± 16.1
nm depending on zein to DNA ratio, and maximized DNA encapsulation efficiency and
loading of 65.3 ± 1.9% and 6.1 ± 0.2 mg DNA/g, respectively. Zein/DNA spheres also
exhibited sustained DNA release in PBS over 7 days with a minimal burst release during
initial phase of release (Regier 2011; Regier, Taylor et al. 2012). Yet, the potential of
these zein/DNA nanospheres to protect their DNA cargo from DNA nucleases and to
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interact with cells remained uncharacterized.

2.3.1 DNA integrity
The integrity of the plasmid DNA integrity is necessary for efficient gene delivery,
specifically maintenance of the supercoiled conformation; thus integrity measurements
were previously made to ensure that encapsulation of the DNA within the zein spheres
did not damage the DNA structure (Regier 2011). Agarose gel electrophoresis revealed
that DNA was not damaged by encapsulation under the conditions used in this study
(Figure 2-1A). DNA integrity was also maintained in spheres during seven days of
incubation in PBS for the release studies (Figure 2-1B and1C). While the stability of the
DNA in and released from zein particles is critical for the success of gene delivery, it also
suggests this stability is superior to that of DNA encapsulated in PLGA microspheres,
which produce degradation products that lower the local pH and can degrade DNA (Jang,
Bengali et al. 2006).

DNA is also susceptible to in vivo biological clearance through degradation by cellular
defense enzymes, known as endonucleases (Agarwal and Mallapragada 2008). These
endonucleases are enzymes that cleave and damage DNA resulting in a nonfunctional
plasmid. An essential determinant of transfection efficiency of these spheres is their
ability to protect encapsulated DNA against endonucleases and therefore they were
evaluated with a DNase I assay. Zein nanospheres showed protection of encapsulated
DNA from DNase I degradation, with DNA concentrated at the top of the gel and unable
to migrate from the loading well, due to its strong interaction with zein (Figure 2-1D).
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The presence of some degradation products can be attributed to surface-associated DNA
on the zein spheres (evident in lane 4), but the majority of the DNA remained intact and
encapsulated. Therefore, these results suggest that zein provides sufficient protection of
DNA during encapsulation, release and presence of DNaseI and has the potential to be a
good polymer choice for gene delivery applications.

Figure 2-1: Agarose gel electrophoresis images of extracted samples for spheres made at
various zein to DNA ratios (A): lane 1, ladder; lane 2, stock DNA; lane 3, 20:1 spheres;
lane 4, 20:1 supernatant; lane 5, 40:1 spheres; lane 6, 40:1 supernatant; lane 7, 80:1
spheres; lane 8, 80:1 supernatant; lane 9, 160:1 spheres; lane 10, 160:1 supernatant; lane
11, 250:1 spheres; lane 12, 250:1 supernatant; lane 13, stock DNA; lane 14 ladder.
Agarose gel image of DNA extracted from spheres (B) and supernatants (C) at various
time points in the PBS release study: lane 1, ladder; lane 2, stock DNA; lane 3, 0 hr; lane
4, 1 hr; lane 5, 3 hr; lane 6, 6 hr; lane 7, 9 hr; lane 8, 12 hr; lane 9, 24 hr; lane 10, ladder;
lane 11, 48 hr; lane 12, 72 hr; lane 13, 96 hr; lane 14, 120 hr; lane 15, 144 hr; lane 16,
168 hr; lane 17, stock DNA; lane 18, ladder. (D) Agarose gel electrophoresis images of
DNA in DNase I degradation assay: lane 1, ladder; lane2, stock DNA; lane 3, Naked
DNA + DNase I; lane 4, 80:1 spheres + DNase I; lane 5, blank spheres (zein with no
DNA); lane 6 80:1 spheres; lane 7, stock DNA; lane 8, ladder.
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2.3.2 Cell studies
Cell studies were conducted to determine biocompatibility, cellular association and
internalization of the zein/DNA particles. Biocompatibility of the zein/DNA spheres
with HEK 293T and Caco-2 cell lines was measured using a WST-1 assay. For HEK
293T cells, absorbance values at a wavelength of 430 nm after 24 hours showed
statistically significant differences between cells that were dosed with zein/DNA particles
(2 µg) and the control (cell only) condition, but at 48 and 72 hours, all zein/DNA
conditions resulted in absorbance values that were not statistically significantly different
from the control condition, indicating no cytotoxicity (Figure 2-2A). For Caco-2 cells,
absorbance values at a wavelength of 430 nm at all times points (24, 48 and 72 hours)
showed no statistically significant differences between cells that were dosed with
zein/DNA particles and the control (cell only) condition, except for two concentrations of
zein/DNA nanoparticles (2µg and 1µg of DNA at 48 and 72 hours, respectively), where
absorbance values were significantly increased (p<0.05) over the control condition,
suggesting an increase in cell proliferation, similar to previous studies that have shown
that the degradation products of zein can enhance cell proliferation (Sun, Dong et al.
2005). For both cell types a lack of a dose response was observed, in that the addition of
more spheres did not result in increased cytotoxicity as measured by the WST-1 assay,
indicating that even at high doses, the zein/DNA spheres were biocompatible. In addition,
morphology appeared normal for both cell types incubated with zein/DNA nanospheres
as seen in Figure 2-3. These results demonstrate that the spheres in this current study
possess biocompatibility with cells.
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Figure 2-2: Cytotoxicity of zein-DNA nanospheres quantified by WST assay for (A)
HEK 293T and (B) Caco-2 cells as a function of time and DNA dose. Control condition
represents cells without the addition of particles. Data points labeled with the same letter
are not significantly different (p<0.05). Data reported as mean ± standard error of the
mean, with n=3.
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Figure 2-3: Cell images (A) HEK 293T control (B) HEK 293T with 0.5 µg zein/DNA
spheres (C) Caco-2 control (D) Caco-2 with 0.5 µg zein/DNA spheres. All images taken
at 100X. Scale bar represents 100 µm.

To further assess internalization of the zein nanospheres within the Caco-2 cells, cellular
membranes were stained with Vybrant DiO and then confocal imaging was used to
visualize both the membrane and sphere locations (Figure 2-4). Sphere internalization
was observed in over half of the cells in any particular image (Figure 2-4A). Further
analysis of individual cells that were shown to be associated with spheres, through
examination of individual z planes within the plane of the cell, confirmed internalization
of the spheres. For instance in Figure 2-4B, two zein particles in the XZ plane are clearly
internalized, which is further confirmed in the YZ plane. Punctate green staining within
cells is indicative of endosomes. While transfection was not observed within the time
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course of these internalization studies due to slow release profile of DNA from the
spheres, these results suggest that DNA/zein nanospheres can enter cells and thus be used
to deliver DNA when properly optimized.

Figure 2-4: Analysis of sphere internalization within Caco-2 cells, with DiO membrane
staining, using merged fluorescence confocal images of entire z-stack with orthogonal
views, XZ and YZ (A) and a digital magnification of the area outlined by a white square
in A (B). Punctate green staining within cells are indicative of endosomes. Filled arrows
indicate internalized, autofluorescent nanospheres. Scale bars in A and B represent 50
and 20 μm, respectively.

2.4 Conclusions
In this work, zein, a natural protein, was further investigated as a possible material for the
formation of spheres encapsulating DNA for gene delivery. Zein is a protein that is
insoluble under physiological conditions, which can allow for sustained release of
encapsulated compounds and enable zein to act more like a hydrophobic polymer (e.g.
PLGA). Zein is biocompatible and has degradation products that can enhance cell
proliferation (Sun, Dong et al. 2005). Furthermore, part of the N-terminal region of
zein has been shown to interact with cell membranes and has served as a peptide
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carrier for drugs across cell membranes (Fernandez-Carneado, Kogan et al. 2004). Zein is
commonly used in pharmaceutical tableting and coating, and is considered most
promising for applications in edible and biodegradable packaging and coatings as well as
biomedical applications (Lawton 2002). Zein has also shown great potential in the field
of drug delivery (Mathiowitz, Bernstein et al. 1993; Sun, Dong et al. 2005; Gong, Wang
et al. 2006), but previous studies have focused on small molecule, hydrophobic drugs.
However, properties of zein make it well-suited for the development of nonviral gene
delivery systems. Here, zein nanospheres encapsulating DNA, formed and optimized
from previous work (Regier 2011), demonstrated the ability to protect cargo DNA from
endonucleases, and when delivered to cells showed acceptable biocompatibility, with
high levels of cell association and internalization (Regier, Taylor et al. 2012). Future
work will include modifications to improve cellular uptake and transfection, as well as
design components to engineer these particles for particle DNA delivery applications,
including oral gene delivery, intramuscular injection, and in the fabrication of tissue
engineering scaffolds.
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CHAPTER 3: Zein Films for Substrate-Mediated Gene Delivery

3.1 Background
Gene delivery, the introduction of exogenous DNA into cells with subsequent expression,
is applicable to the fields of gene therapy (Niidome and Huang 2002), DNA vaccination
(Donnelly, Ulmer et al. 1997) functional genomics and diagnostics (Pannier, Ariazi et al.
2007), tissue engineering (Shea, Smiley et al. 1999), and biomedical devices (Zilberman,
Kraitzer et al. 2010). Nonviral gene delivery is often explored due to its simplicity of
manufacturing, flexibility in transgene capacity, and lower immunogenicity over its
counterpart of viral delivery (Mintzer and Simanek 2009). Typically, formation of
nonviral vectors is accomplished through complexation of negatively charged DNA with
cationic polymers or lipids and then is delivered as a bolus to cells (Segura and Shea
2001). However, this bolus addition of complexes has limitations in mass transport to
cells or can be hindered by deactivation processes such as degradation, aggregation or
clearance of DNA complexes from cells or tissues (Segura, Volk et al. 2003), resulting in
uneven distribution of complexes and lower transfection levels. The need for a controlled
and efficient gene delivery system is a crucial component to many applications and thus,
alternative delivery strategies have been investigated for increasing location and levels of
transfection efficiency. Substrate-mediated gene delivery (SMD), also termed reverse
transfection (Ziauddin and Sabatini 2001), or solid-phase delivery (Bielinska, Yen et al.
2000), describes a delivery system where complexes are immobilized to a surface that
supports cell adhesion; cells are then seeded on top of the immobilized DNA complexes
(Segura, Volk et al. 2003; Bengali, Pannier et al. 2005; Bengali and Shea 2005; Pannier,
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Anderson et al. 2005). The immobilization of complexes allows for concentrated amounts
of DNA in the local environment of cells (Shea, Smiley et al. 1999; Luo and Saltzman
2000) and limited aggregation of complexes, and has been shown to enhance gene
delivery (Bengali, Pannier et al. 2005; Bengali, Rea et al. 2009; Segura, Volk et al. 2003;
Pannier, Anderson et al. 2005). SMD can also be used as a patterning strategy to spatially
control delivery on a surface, in applications such as transfected cell arrays (Pannier,
Anderson et al. 2005) and tissue engineering scaffolds (Jang, Bengali et al. 2006). This
alternative approach to gene delivery has been examined widely, using polyplexes
(Bengali, Pannier et al. 2005; Bengali, Rea et al. 2009), lipoplexes (Segura, Volk et al.
2003; Pannier, Anderson et al. 2005; Bengali, Rea et al. 2009), and viral vectors (Levy,
Song et al. 2001; Shin, Salvay et al. 2010). Vectors can be immobilized through nonspecific interacations (hydrophobic, electrostatic and van der Waals) (Bielinska, Yen et
al. 2000; Kneuer, Sameti et al. 2000; Manuel, Zheng et al. 2001; Zhang, Chua et al. 2004;
Bengali, Pannier et al. 2005) or specific interactions (antigen-antigbody or biotin-avidin)
(Levy, Song et al. 2001; Segura and Shea 2002) to the substrate.

Previous work has demonstrated the potential of SMD with different substrates including
polysterene (Bengali, Pannier et al. 2005), metal stents (Fishbein, Alferiev et al. 2006)
and self-assembled monolayers (SAMs) of alkanethiols on gold (Pannier, Anderson et al.
2005), as well as surface-coatings including fetal bovine serum (FBS)-coated polystyrene
(Bengali, Pannier et al. 2005) and PLGA (Jang and Shea 2003; Jang, Bengali et al. 2006),
collagen- coated polyurethane (Stachelek, Song et al. 2004) and PLGA (Shin, Salvay et
al. 2010), and fibronectin- coated polysterene (Bengali, Rea et al. 2007) and PLGA (Shin,
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Salvay et al. 2010). While SMD has demonstrated increased gene transfer compared to
the traditional bolus technique in several previous studies (Segura, Volk et al. 2003;
Bengali, Pannier et al. 2005; Bengali, Rea et al. 2009), SMD has only been used with a
few different surfaces and model biomaterial substrates; other surface materials, in
particular surface coatings consisting of natural biomaterials, need to be explored for
their ability to translate or improve SMD to applications including biomedical devices
(e.g. implants or stents), tissue engineering scaffolds, and transfected cell arrays.

Zein is the prolamin or storage protein from corn and has many physical and biological
properties that make it a promising candidate material for substrate-mediated gene
delivery, in particular its ability to naturally form films. Zein is amphiphilic (Wang,
Wang et al. 2004) with more than 50% of its 225 amino acid residues (Geraghty, Peifer et
al. 1981) being hydrophobic (Cabra, Arregun et al. 2005), including high percentages of
leucine, proline, and alanine, in addition, zein has a high glutamine content (Pomes 1971;
Padua Graciela and Wang 2009), contributing polar, protonable side chains. With its
amphiphilic character (Wang, Wang et al. 2004), zein is most commonly dissolved in
aqueous ethanol. Zein films can be formed by a simple technique of evaporation induced
self-assembly (EISA), that relies on the different evaporation rates of zein’s solvent (i.e.,
ethanol and water), to form a film upon drying (Wang and Padua 2012; Dong, Padua et
al. 2013). The resulting zein films are tough, glossy, hydrophobic, and resistant to
microbial attack, while maintaining flexibility and compressibility (Shukla and Cheryan
2001). Due to these excellent film properties, zein films have been widely used in the
food industry as coatings and packaging materials for fruits, vegetables, and nuts (Shukla
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and Cheryan 2001). In addition, zein is biocompatible, degrades slowly in physiological
conditions, and its degradation products have been shown to enhance cell proliferation
(Sun, Dong et al. 2005), thus zein films have been used in the pharmaceutical industry, as
coatings for medical tablets for controlled release systems (Winters and Deardorff 1958).
Due to all of the aforementioned properties, zein films have also been investigated as a
scaffold to support cell adhesion for biomedical implants (Gong, Wang et al. 2006;
Wang, Gong et al. 2007), such as a drug- eluting film for cardiovascular devices (Wang,
Lin et al. 2005), and as a particulate for DNA delivery (Regier, Taylor et al. 2012). With
such versatility, the objective of this chapter was to investigate zein films as a surface
coating for substrate-mediated gene delivery, examining specific parameters of the films
for their influence on transfection.

3.2 Materials and Methods
3.2.1 Plasmid preparation
All experiments used pEGFP-Luc (Clontech, Mountain View, CA), a plasmid encoding
for both the green fluorescent protein, GFP, and the firefly luciferase protein, LUC, under
the direction of a CMV promoter. The plasmid was purified from bacteria culture using
Qiagen (Valencia, CA) reagents and stored in Tris-EDTA (TE) buffer solution (10 mM
Tris, 1mM EDTA, pH 7.4) at -20 °C. Only plasmids with purity of 1.8 or better measured
by 260/280 ratio (Nanodrop 2000 Spectrophotometer, Thermo Scientific, Waltham, MA)
were used.
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3.2.2 Film formation
Zein films were formed using an evaporation-induced self-assembly (EISA) technique.
Films were formed on 8 mm round cover glass slides (Electron Microscopy Sciences,
Hatfield, PA). The glass slides were placed on a stage inside a well of a 24-well plate.
Several fabrication conditions were varied. For studies investigating zein concentration,
zein (Freeman Industries LLC, Tuckahoe, New York) was first dissolved in 55% ethanol
forming a 0.2%, 0.4% or 0.8% w/v zein solution. Subsequently, the zein solution pH was
adjusted using 1M sodium hydroxide to a obtain pH value of 9. For studies investigating
the effect of pH, zein (Freeman Industries LLC, Tuckahoe, New York) was first
dissolved in 55% ethanol forming a 0.4% w/v zein solution. Subsequently, the zein
solution pH was adjusted using 1M hydrochloric acid or 1M sodium hydroxide to obtain
pH values of 2, 4, 7, 9 or 12. For each condition tested, concentration or pH, 60 µL of the
zein solution was pipetted onto the glass slide resting on a stage in a well of a 24-well
plate. The lid of the well plate was placed on top, leaving a small gap for air movement
for evaporation overnight. Films were used the next day.

3.2.3 Film surface characterization
Scanning electron microscopy (SEM, S-3000N Hitachi, Japan) was used to image the
entire film surface (from center to edge) for subsequent analysis of film morphology and
uniformity. For SEM imaging films were formed on glass slides as described above and
dried in an oven for 1 hr at 120° C. The glass slides with zein films were placed on
carbon tape (Electron Microscopy Sciences) and mounted for sputter coating. Films were
then sputter coated with chromium and imaged at 20 kV and varying magnifications. A
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minimum of two micrographs for each concentration and pH were analyzed using ImageJ
(NIH, Bethesda, MD) to determine average sphere diameter. A macroscopic image was
also taken with a Galaxy SIII phone camera, to observe difference in appearance of films
with regards to concentration and pH.

3.2.4 Contact angle measurements
Static water contact angle (WCA) measurements were carried out using a Ramé-Hart
Instruments Goniometer. An image was taken after 10 µL of ddH2O was pipetted onto
the surface of pH 2 and pH 4 zein films. Angle measurements were analyzed using
Ramé-Hart Imaging Software.

3.2.5 Degradation
Degradation studies were carried out for a predetermined time in 1X phosphate buffered
saline (PBS) at a temperature of 37° C to mimic the physiological environment of the
human body. Zein films were placed in a 48-well plate with 300 µL of PBS. After
specified times, the PBS was removed and zein films were dried in an oven at 120° C for
1 hr. SEM, as described above, was used to observe and analyze degradation of the zein
films.

3.2.6 Complex formation
DNA complexes were formed using either a cationic polymer, polyethyleneimine (PEI)
(Sigma-Aldrich, St Louis, MO, USA), or cationic lipid, Lipofectamine 2000 (LF2000;
Invitrogen). For polyplexes, branched 25 kDa PEI was dialyzed with 10,000 MWCO
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Slide-A-Lyzer against ddH2O, lyophilized, dissolved in TE buffer at 1 mg/ml and stored
at –20° C. PEI/DNA polyplexes were formed at a nitrogen to phosphate (N/P) ratio of 25
in 1X Tris buffered saline (TBS) solution by dropwise addition of PEI solution to plasmid
DNA (pDNA) solution, the PEI/DNA mixture was briefly vortexed for 10 s, and
incubated for 15 min at room temperature. LF2000/DNA lipoplexes were formed
following manufacturer’s instructions. Briefly, DNA complexes were formed at a
DNA:lipid ratio of 1:2 (μg of DNA to μl of LF2000) in serum-free, Opti-MEM media
(Invitrogen) by adding transfection reagent diluted in media to DNA in media, mixing by
gentle pipetting, and incubating for 20 min. Once complexes were formed, 60 µL (final
volume of complexes with 2µg of DNA) was added to each of the zein films for loading,
release and transfection studies. All complexation conditions were selected based on
optimization of transfection.

3.2.7 Quantification of DNA complex loading
For loading studies, DNA complexes were adsorbed to zein films formed at different pH
conditions, as described above. At predetermined time points, complexes were removed
and collected from zein films. Films were then washed with either TBS or Opti-MEM
and this wash solution was also collected. In order to quantify the amount of DNA
adsorbed to the surface of zein films, the amount of DNA that did not adsorb to the films
was determined and subtracted from the total amount of DNA added to the well. For
LF2000/DNA complexes, removed complexes were dissociated with a 2 mg/mL final
concentration of heparin (Sigma-Aldrich, St Louis, MO). Solutions were briefly vortexed
and incubated at room temperature for 30 min. After incubation, solutions were then
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diluted appropriately in 1X TNE buffer (10 mM Tris; 0.2 M NaCl; 1 mM EDTA; pH
7.4), mixed with one volume Hoechst dye solution (200 ng/mL) and fluorescence was
measured by a fluorometer (Modulus Luminometer/Fluorometer, Turner Biosystems,
Sunnyvale, CA) after 5 min. incubation at room temperature. A Hoechst standard curve
was produced by graphing raw fluorescence versus DNA concentration for various
dilutions of the stock DNA solution. For PEI/DNA complexes, removed complexes were
diluted appropriately in 1X TNE buffer (10 mM Tris; 0.2 M NaCl; 1 mM EDTA; pH
7.4), mixed with one volume Hoechst dye solution (200 ng/mL) and fluorescence was
measured by a fluorometer (Modulus Luminometer/Fluorometer, Turner Biosystems,
Sunnyvale, CA) after 5 min. incubation at room temperature. A Hoechst standard curve
was produced by graphing raw fluorescence versus PEI/DNA complex concentration for
various dilutions of the stock DNA solution. For either complex type the standard curve
was then used to quantify the amount of DNA removed from the films, using
fluorescence measurements that were first normalized to the fluorescence of blank
complex solutions (no DNA added). Equation 1 was used to determine the amount of
DNA adsorbed on the zein films.

3.2.8 Cell culture
Human embryonic epithelial kidney cells, HEK 293T (ATCC, Manassas, VA), were
cultured in T-75 flasks in Dulbecco’s modified Eagle’s medium (DMEM, Gibco/
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Invitrogen, Carlsbad, CA) containing 4.5 g/L glucose and supplemented with 10% fetal
bovine serum (FBS, Gibco), 2 mM L-glutamine (Gibco), and 1% penicillin/ streptomycin
(Gibco). For seeding, cells were counted using a hemocytometer and trypan blue staining
for viable cells after being dissociated with 1 mM EDTA. Cells were seeded into 48-well
plates at a density of 30,000-33,000 cells per well for transfection and cell viability
studies.

3.2.9 Transfection
Transfection studies were performed on zein films formed at different zein concentrations
and also different pH conditions containing a final DNA amount of 0.4 μg per well. After
complex formation and adsorption (2 hrs), HEK 293T cells were seeded onto zein films
as described above. Fluorescence microscopy was conducted at 48 hours after seeding
cells to confirm the successful expression of the EGFP protein using a Leica DMI 3000B
fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany). Transfection
levels were analyzed following 48 hours of culture by quantification of luciferase activity
using the Luciferase Assay System (Promega), for which cells were lysed and assayed for
enzymatic activity using a luminometer (Turner Designs, Sunnyvale, CA), and luciferase
activity (RLUs) was normalized to area (1cm2 ). LF2000/DNA transfection experiments
were performed in triplicate on duplicate days (n=6), except for pH 2 and pH 4 films
(n=5). PEI/DNA transfection experiments were performed in triplicate (n=3), for all zein
films at different pH conditions.
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3.2.10 Cell viability
Cell viability was assessed using a Water Soluble Tetrazolium (WST-1) salts cell
proliferation assay kit (Roche, Indianapolis, IN). For the WST-1 assay, films containing a
final DNA amount of 0.4 μg of DNA were formed. Cells were seeded in 48-well plates
on the zein films as described above and after 24, 48 and 72 hours of culture, cells were
imaged to observe cell morphology (Leica DMI 3000B, Bannockburn, IL) and the WST1 assay was conducted according to the manufacturer’s protocol. Briefly, cells were
washed with 1X PBS, transferred to a new well and incubated at 37°C with the WST-1
solution (10 vol.% WST-1 reagent in phenol-free DMEM, 250µl/well). After incubation
for 3 hours, absorbance values of WST-1 solution (150 μl from each well) were measured
on an Epoch Microplate spectrophotometer (BioTek, Winooski, VT) at a wavelength of
430 nm and normalized to area (1cm2 ). Assays were performed in triplicate.

3.3 Statistics
All experiments were performed in triplicate, unless otherwise stated. Comparative
analyses were completed using a one- or two-way ANOVA followed by Tukey’s multiple
comparison test or Bonferroni posttest, respectively for multiple data points, both at a
95% confidence level using Prism software (GraphPad Prism 5, LaJolla, CA). Mean
values with standard error of the mean are reported for all data.
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3.4 Results
3.4.1 Optimization of Zein Concentration for Film Formation
Zein films were formed by EISA and investigated for their ability to support SMD. First,
the concentration of zein solution used to form the films was varied, to optimize film
morphology and coverage. From SEM images and analysis (Figure 3-3A-F), zein films
formed from all concentrations were comprised of spheres, as previously reported (Dong,
Padua et al. 2013). Different zein concentrations impacted the uniformity of the film and
sphere size. Films formed with the lowest concentration of zein, 0.2%, were comprised of
0.99

0.07 nm spheres and did not produce a uniform film over the underlying glass

substrate, as seen in Figure 3-1A and 3-1B and shown by others (Dong, Padua et al.
2013). The highest zein concentration tested, 0.8%, formed a microsphere film comprised
of the largest spheres (Figure 3-1E), 1.8

0.11 nm, however the sphere sizes varied

dramatically around the edge of the film, ranging from 1.5

0.14 nm to 5.6

0.99 nm

(Figure 3-1F). The most uniform film was formed from a 0.4% zein solution, with
homogenous spheres of 0.99

0.08 nm, and full film coverage of the underlying surface

from center to edge (Figure 3-1C and 3-1D). Differences in zein films formed at various
conentrations can aslo be observed macroscopically (Figure 3-3G), which confirms SEM
results that show films formed from 0.4% zein solutions have the most uniform
appearance.
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Figure 3-1. SEM of zein films comprised of spheres, (A, B) 0.2% (0.99 0.07 nm
spheres with incomplete surface coverage), (C, D) 0.4% (0.99 0.08 nm spheres with
full surface coverage), (E, F) 0.8% (1.8 0.11 nm spheres in center with 1.5 0.14 nm
to 5.6 0.99 nm spheres around edge, with uneven surface coverage); and (G)
Macroscopic image of different concentrations of zein films.
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In addition to optimizing zein solution concentration for film uniformity, the
concentration was also optimized for SMD transfection in HEK 293T cells. By varying
the amount of added DNA, the DNA:lipid ratio for lipoplexes (data not shown), the
optimal conditions for high transfection and low cytotoxicity were found to be at a
DNA:lipid ratio of 1:2 for polyplexes, and 2 µg of DNA concentration. Thus, complexes
formed with 2µg DNA and LF2000 at a 1:2 DNA:lipid ratio were added to these films for
adsorption over two hours. While all surfaces supported transfection, films formed from
0.2% and 0.4% zein solutions exhibited significantly higher transfection levels (p < 0.05,
p < 0.01, respectively), than transfection on the films formed from 0.8% zein
concentration, determined through luciferase activity (Figure 3-2A) and fluorescent cell
images (Figure 3-2B-D) of EGFP expression. Thus, films formed using 0.4% (w/v) zein
solution were used throughout the remainder of this chapter due their uniformity in
surface coverage and high transfection levels.
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Figure 3-2. SMD Transfection levels of different concentrations of zein films, reported as
relative light units (RLU) normalized to area (A), and SMD transfection images of HEK
293T cells with LF/DNA complexes on (B) 0.2%, (C) 0.4%, and (D) 0.8% zein films.
Data reported as mean standard error of the mean, with n=3.
(*p < 0.05, **p < 0.01).

3.4.2 Morphology of Zein Films formed at Different pH conditions
Given that zein is amphiphilic and its surface charge varies with pH (Deo, Jockusch et al.
2003; Wang, Wang et al. 2004), the effect of the pH of zein solution on the morphology
of the resulting zein films was investigated. Films formed from zein solutions at pH 2
formed a smooth, flat film with minor cracks (Figure 3-3A). Films formed from zein
solutions at higher pH levels (4-12), were comprised of spheres (Figure 3-3 B-E), as seen
above with the different concentrations of zein (Figure 3-1A). Average sizes of the
spheres that constituted the films ranged from 1.07
µm (Figure 3-3C), 0.66

0.5 µm (Figure 3-3B), 1.56

0.2 µm (Figure 3-3 D), to 0.59

0.4

0.2 µm (Figure 3-3 E) for pH

66

4, 7, 9 and 12 zein films, respectively, and are shown in Figure 3-3G. Differences in zein
films formed from solutions at different pH conditions were also observed
macroscopically (Figure 3-3F), ranging from a translucent appearance (pH 2) to more
opaque films at higher pH levels.

Figure 3-3. SEM images (7k magnification, scale bar 5 µm), of zein films formed at
solution at pH 2 (A), (B) pH 4, (C) pH 7, (D) pH 9, (E) pH 12; and (F) Macroscopic
images of zein films formed from different pH conditions and (G) average diameter of
spheres from each pH level measured from SEM images, reported as mean standard
error of the mean.

3.4.3 Contact Angle
The WCA of the pH 2 and pH 4 zein films were measured due to the morphological
difference between the two films and revealed a WCA of 21.7° for pH 2 (Figure 3-4A)
and 9.8° for pH 4 (Figure 3-4B).
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Figure 3-4. The water contact angle of (A) pH 2, and (B) pH 4 zein films.

3.4.4 Degradation
Zein films formed from solutions at different pH conditions were incubated in PBS over a
determined period of time and degradation of the films was evaluated through SEM
(Figure 3-5). After 72 hours of incubation in PBS, pH 4, 7 and 12 films displayed larger
degradation pore sizes of approximately 1.8 µm, compared to films formed from
solutions at pH 2 and 9, which maintained a smoother film surface with smaller
degradation pores. The addition of PBS to zein films formed from solutions of pH 12
resulted in partial removal of the film from the glass slide; therefore this condition was
not further evaluated.
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Figure 3-5. SEM images (7k magnification, scale bar 5 µm) of zein film degradation in
PBS after 72 hours.

3.4.5 Quantification of Surface Adsorbed DNA complexes
As varying the pH of the zein solution used to form the film could result in a change in
surface charge (confirmed by WCA), the effect of pH on the loading of non-specifically
adsorbed complexes on the films was analyzed. Both LF/DNA and PEI/DNA complexes
were adsorbed on zein films for specified time points and then complexes that did not
adsorb were collected. The amount of DNA immobilized to the surface was quantified by
measuring the DNA removed and collected. Quantifying the DNA in the lipoplexes was
performed by dissociating the complexes with heparin and then using Hoescht, a
fluorescent dye that binds DNA, to measure the fluorescence of the sample. For
PEI/DNA complexes, a standard curve of known concentration of complexes was used to
measure the amount of complexes removed using Hoescht. The amount of DNA
immobilized to the surface increased with time for both type of complexes (Figure 3-6),
but varied per substrate. For lipoplexes, the rate of absorption was initially slow, as there
was only a 4% increase in mass over two hours (Figure 3-6A). After 4 hours of lipoplex
adsorption, zein films at pH 4 had a significant increase in absorption of complexes
compared to zein film at pH 9 (p<0.01). At the end of the 8 hour adsorption period,
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statistically significant differences of DNA absorption between pH 4 and pH 7 (p<0.01),
pH 4 and pH 9 (p<0.001), and pH 7 and pH 9 (p<0.01) with a maximum DNA absorption
of 51 %, 44 %, and 41% for pH 4, 7 and 9 films, respectively, were observed. This
maximum absorption decreased linearly with increasing pH (r2=0.99). However, after
two hours of incubation, all zein films showed DNA loading of approximately 20% of the
total amount added to the surface (Figure 3-6A), indicating a total of 0.4 µg of DNA,
which was used for further experiments in this chapter. Like lipoplexes, PEI/DNA
absorption mass and rate was significantly different between zein film conditions. After
two hours, DNA absorption on pH 2 and pH 9 zein films was significantly lower
compared to both pH 4 and pH 7 zein films (Figure 3-6B). At later time points, zein films
formed at pH 2 had significantly reduced DNA absorption as compared to the other zein
films at pH 4 (p<0.01), pH 7 (p<0.05) and pH 9 (p<0.01) . However, 100% of polyplexes
were adsorbed on all zein films by 24 hours. PEI/DNA complexes absorbed faster than
LF/DNA complexes in that 46-56% of polyplexes were absorbed on zein films after two
hours, while 21% of DNA from lipoplexes were absorbed on zein films. The two hour
adsorption of PEI/DNA polyplexes resulted in a range of 0.92 µg to 1.12µg of total
adsorbed DNA, and was chosen for further experiments in this chapter.
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Figure 3-6. Absorption of (A) LF/DNA and (B) PEI/DNA complexes on zein films
formed at different pH conditions. Data reported as mean standard error of the mean,
with n=3.
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3.4.6 Substrate-Mediated Transfection on Zein Films
To examine the influence of different zein film fabrication parameters on SMD
transfection, LF/DNA or PEI/DNA complexes previously optimized for high
transfection and low cytotoxicity (data not shown), were adsorbed onto zein films
(prepared from solutions at different pH conditions) for two hours, HEK 293T cells were
seeded and transfection profiles were acquired 48 hours following seeding. Transfection
profiles were measured using both fluorescence microscopy to image EGFP expression,
and the luciferase assay, where average relative light units (RLU) of luciferase
luminescence for each sample were normalized to area. Although the amount of DNA
adsorbed to the surface of zein films (at two hours) was independent of pH for lipoplexes,
but dependent on pH for polyplexes, transfection levels in HEK293T cells for both types
of complexes displayed a dependent trend with pH (Figures 3-7A-D and 3-8A).

Transfection mediated by LF/DNA complexes adsorbed to the zein films formed from
different pH solutions generally increased with increasing pH of the films (Figures 3-7AD, Figure 3-8A). Cells seeded on pH 9 films achieved the highest transfection levels in
terms of average RLU/cm2 for lipoplex transfection, which was nearly 2.5-fold greater
than transfection on pH 4 zein films (Figure 3-8A). Transfection levels mediated by
PEI/DNA complexes adsorbed on the zein films were significantly lower than lipoplex
transfection, however a similar trend was observed with varying pH of the zein films
(Figure 3-8B). Gene expression levels were statistically different between pH 2 and pH 9
films (p<0.05), with nearly 2.8-fold enhancement of PEI-mediated transfection on the pH
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9 zein films as compared to pH 2 films (Figure 3-8B). These results demonstrate that
zein films can support substrate-mediated transfection, in a pH-dependent manner.

Figure 3-7. SMD transfection images of HEK 293T cells with LF/DNA complexes on
(A) pH 2, (B) pH 4, (C) pH 7 and (D) pH 9 zein films. Scale bars represent 100 µm.
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Figure 3-8. Normalized SMD transfection profile for HEK 293T cells plated on zein
films formed from different pH solutions, mediated by (A) LF/DNA complexes (n=5 or
6) and (B) PEI/DNA complexes (n=3). Data reported as mean standard error of the
mean.

3.4.7 Cell Viability
The viability of HEK 293T cells seeded onto the zein films loaded with LF DNA
complexes was measured using a WST-1 assay over 72 hours (Figure 3-9). Polysterene
(PS) with adsorbed complexes was used as a control. Cells on zein films displayed a
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slower proliferation rate compared to those on the control PS surface from 24 to 48 hours.
However, from 48-72 hours, pH 7 and 9 zein films had similar or higher proliferation
rates than PS.

Figure 3-9. Viability of cells on zein films with adsorbed LF/DNA complexes quantified
by WST-1 assay for HEK 293T cells as a function of time. The slope of the lines
connecting each set of consecutive time points is indicative of the rates of cell
proliferation. Data reported as mean standard error of the mean, with n=3, except for
pH 2, where no data was collected at 24 hours.

3.5 Discussion
Substrate-mediated delivery (SMD) is an alternative approach to traditional bolus gene
delivery, and describes the immobilization of DNA to a cell-adhesive substrate prior to
cell seeding (Bengali, Pannier et al. 2005; Bengali and Shea 2005; Pannier, Anderson et
al. 2005; Jang, Bengali et al. 2006; Bengali, Rea et al. 2007). This mechanism not only
allows for an increase in concentration of DNA within the direct microenvironment of
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cells (Luo and Saltzman 2000), but also limits aggregation of complexes and has been
shown to enhance nonviral gene delivery, compared with bolus delivery, with the
potential for spatially controlling transfection through patterned delivery (Pannier,
Anderson et al. 2005; Houchin-Ray, Whittlesey et al. 2007). However, limitations of
SMD have included the limited understanding of interactions between the properties of
both vector and substrate for optimal transfection profiles, as well as ill-defined surface
coatings that may be difficult to translate to in vivo biomedical devices and scaffolds.
Thus, there is still a need for investigating new surface coatings to further develop an
efficient and controlled DNA delivery system. Here, zein films were explored for their
ability to support SMD.

Zein, a natural protein from corn, is biodegradable, biocompatible, amphiphilic, resistant
to microbial attack, promotes cell proliferation and can encapsulate plasmid DNA
(Shukla and Cheryan 2001; Wang, Wang et al. 2004; Sun, Dong et al. 2005; Regier,
Taylor et al. 2012). In addition, zein is known as an excellent film former and commonly
used in pharmaceutical tableting and coatings, which makes it a promising material for
biomedical applications (Fernandez-Carneado, Kogan et al. 2004). Due to the desirable
properties of this natural biomaterial, zein films that can support SMD could be used in a
multitude of biomedical applications such as coated- implants, tissue engineering, and
transfected cells arrays (Shea, Smiley et al. 1999; Pannier, Ariazi et al. 2007; Zilberman,
Kraitzer et al. 2010). In this chapter, zein films were formed after evaporation induced
self-assembly (EISA). This mechanism involves the preferential evaporation of one of the
solvents of a binary or tertiary solvent, causing a polarity change in the solution, which
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drives the self-assembly of zein (Wang and Padua 2010; Wang and Padua 2012).
Different zein structures, such as spheres, hexagonal, sponge and lamellar phases have
been formed after EISA (Wang, Yin et al. 2008; Wang and Padua 2010). The zein films
formed in this chapter were all composed of spheres, except for films formed from a pH 2
zein solution. The sphere formation in the zein films can be attributed to zein being
amphiphilic and having defined hydrophobic and hydrophilic (glutamine-rich) regions
(Pomes 1971; Matsushima, Danno et al. 1997). Zein was dissolved in an aqueous ethanol
solvent and subsequently, during EISA, the polarity of the solvent began to increase as
the ethanol evaporated faster than the water. This increase in polarity forced the
hydrophobic regions of zein to aggregate and reduced their exposure to the hydrophilic
solvent, resulting in spheres. This mechanism results in a hydrophilic film surface, as
confirmed by WCA, composed of spheres (Dong, Padua et al. 2013). Aggregation of
increased number of zein molecules causes the direct relationship of the increased size of
spheres with increased concentration of zein solution, as seen in Figure 3-1 and
previously shown (Dong, Padua et al. 2013).

As stated above, the films formed at pH 9 for all zein concentrations tested were
comprised of spheres and as the concentration of zein increased, the size of spheres
increased (Figure 3-1). The size of spheres comprising the zein films correlates to surface
roughness, with larger sphere sizes corresponding to increased surface roughness. Surface
roughness is a good indicator of hydrophilicity (Sun, Feng et al. 2005). As surface
roughness decreases, the hydrophilicity of the surface increases and thus hydrophilicity
can be controlled through varying surface roughness (Sun, Feng et al. 2005; Dong, Padua

77

et al. 2013). Hydrophilic surfaces have previously been shown to support SMD better
than hydrophobic surfaces due to the reversible interactions between the substrate and
complexes (Bengali, Pannier et al. 2005; Pannier, Anderson et al. 2005). Here, zein films
formed with 0.2% and 0.4% zein concentration achieved higher transfection than 0.8%
zein films, as seen in figure 3-2. This increase in transfection could be the result of lower
surface roughness (i.e. smaller sphere size) of 0.2% and 0.4% compared to that of 0.8%
zein films (Blacklock, Vetter et al. 2010).

Next, the pH of the zein solution was investigated for its effect on the morphology of the
zein films. Zein films formed at pH 2 were flat, smooth and featureless, which is similar
to zein films casted in acetic acid (Shi, Kokini et al. 2009). Films formed at pH values of
4, 7, 9 and 12 showed an inverse relationship between pH of zein film and size of
spheres. As the pH of the film increased, the size of spheres decreased. Zein films formed
at pH 4 and 7 were comprised of larger spheres (greater surface roughness and
hydrophobicity) than pH 9 and 12 zein films. The morphology of zein films can be
explained by the mechanism of EISA. The isoelectric point of zein is 6.8 (Cabra, Arregun
et al. 2005), indicating that when solution pH< 6.8, the glutamine-rich regions
(hydrophilic) of zein are positively charged and negatively charged when solution
pH>6.8. When coating the glass slides, which contain mainly negatively charged silicate
groups, the electrostatic interaction between zein molecules and glass slide will force the
zein molecules to lie down flat to minimize the interaction energy between zein and
glass, as observed in pH 2 solution resulted in a smooth surface seen in Figure 3-2A. For
the other zein films formed at pH values of 4, 7, 9 and 12, the repulsive interactions
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between the zein molecules and glass slide lead to the formation of a film surface being
comprised of spheres (Figure 3-2B-E). The solvent used in zein solution preparation has
previously been shown to affect the orientation of molecules on a substrate (Shi, Kokini
et al. 2009). Zein films formed from acetic acid formed smoother surfaces as compared to
those cast from 95% ethanol aqueous solutions, which were rough and composed of
granules. This morphological difference was due to the conformational difference of the
protein, due to how the zein molecules aggregate on the substrate (Shi, Kokini et al.
2009).

Degradation of zein films in PBS is shown in Figure 3-5. Zein films, pH 2 and pH 9,
appear to have the slowest degradation, which could be attributed to their lower surface
roughness compared to the other zein films. This lower surface roughness may help
maintain the structure of the film longer than the other zein films, especially pH 4 and pH
7. The larger sphere size in pH 4 and pH 7 zein films could have resulted in the increased
pore sizes from degradation upon zein sphere aggregation in PBS, as previously reported
(Regier, Taylor et al. 2012). Despite these slight differences in film degradation, the zein
films demonstrated a slow degradation profile in PBS, which mimics physiological
conditions and can be a good indicator for release of DNA, or an encapsulated drug.
Also, zein degradation products have been shown to enhance cell proliferation (Sun,
Dong et al. 2005), which is another advantageous factor for zein as a natural polymer
choice for SMD compared to commonly used PLGA, where degradation products are
acidic and can induce cell death (Jang and Shea 2003). Degradation of zein films in PBS
confirms the slow breakdown of zein by hydrolysis which is due to zein’s hydrophobic
nature (Hurtado-Lopez and Murdan 2006). This slow degradation could allow for a
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sustained release of complexes over a long period of time that is critical for tissue
engineering applications.

The amount of DNA immobilized to the surface increased with time for all zein films, but
varied with zein films formed at different pH conditions. The maximum adsorption of
DNA from lipoplexes measured from the zein films decreased with increasing pH
(increasing hydrophilicity). Substrate hydrophobicity has been previously shown to
influence the local DNA concentration adsorbed to the surface of the substrate. This trend
of decreased adsorption on hydrophilic surfaces supports other’s results of greater
immobilization of complexes on hydrophobic substrates compared to more hydrophilic
surfaces (Bengali, Pannier et al. 2005; Pannier, Anderson et al. 2005). Even though zein
is hydrophobic, the formed zein film surface appeared to be hydrophilic through surface
roughness by EISA in Figure 3-3 and contact angle measurements as shown in Figure 34, again due to the forced exposure of the hydrophilic residues through EISA. For
polyplexes, the adsorption rate for pH 2 zein films (a more hydrophobic surface) was
significantly lower than other zein films (hydrophilic), which contradicts the above
statement and our LF/DNA adsorption trend of increased adsorption on hydrophobic
surfaces. However, Pannier et al demonstrated decreased absorption on hydrophobic
surfaces when the hydrophilic surface contained 100% charged functional groups
(Pannier, Anderson et al. 2005). In contrast, pH 7 zein films showed a significant
increased adsorption of PEI/DNA complexes compared to pH 9 zein films, which again
agrees with increased adsorption on hydrophobic surfaces. Our results coincide with
others and suggest that non-specific DNA complex adsorption to zein films might be
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mediated by both charge-charge interactions and hydrophobic interactions (Pannier,
Anderson et al. 2005).

Here, zein films loaded with DNA complexes were shown to mediate successful gene
transfer. Transfection mediated by LF/DNA complexes adsorbed to zein films increased
on films formed from solutions of higher pH, which corresponds to surfaces of increasing
hydrophilicity and decreasing surface roughness, confirming other’s work with both
SMD and fabrication of zein films, separately (Bengali, Pannier et al. 2005; Pannier,
Anderson et al. 2005; Dong, Padua et al. 2013). The same trend was seen with PEI/DNA
complexes but at much lower transfection levels, which could be due to an almost 2-fold
increase of PEI/DNA complexes adsorbed to the zein films compared to LF/DNA
complexes resulting in increased toxicity and reduced transfection. However, with
PEI/DNA complexes, transfection was statistically lower on pH 2 zein films than at pH 9.
This difference demonstrates the influence of both hydrophilicity and complex
conformation on transfection since adsorption of complexes was not significantly
different between pH 2 and pH 9 zein films. Pannier et al showed increased transfection
on hydrophilic surfaces as compared to a more hydrophobic surface and suggested the
results were possibly due to the reversible interactions between the substrate and complex
(Pannier, Anderson et al. 2005), where surfaces with greater hydrophobicity may induce
irreversible binding of complexes due to conformational changes upon binding to the
hydrophobic surface (Stuart, Fleer et al. 1991). Adsorption of complexes on hydrophobic
surfaces may alter the complex conformation, resulting in decreased transfection.

81

Cell viability is another factor influencing transfection. The biocompatibility of the zein
films was demonstrated with a WST-1 assay and revealed excellent cell viability
compared to the PS control, except with pH 4 zein films. This lower cell viability on pH
4 zein films could be due to the increased adsorption of LF/DNA complexes compared to
other zein films (Figure 3-6A), which could lead to increased toxicity and reduced
transfection (Figure 3-7A). Conversely, the proliferation rate (slope between two time
points) of zein films at pH 7 and pH 9 was higher than tissue culture PS at 72 hours,
demonstrating that these films are increasing cell proliferation. This increase in
proliferation can be connected with the degradation of zein at 72 hours shown in Figure
3-5 as zein’s degradation products have been shown to enhance cell proliferation (Sun,
Dong et al. 2005).

These studies demonstrate the potential for using zein films as coatings to support SMD.
Further investigation of both the properties of zein films, such as surface charge, and the
properties of the DNA complexes (conformation and release) are needed in order to
better understand the mechanism and design of SMD systems on zein films. Future
improvements could entail embedding of complexes within the film, which would occur
before EISA. Future studies will also examine another method to control release of DNA
by forming DNA-loaded zein spheres, as shown by our previous work (Regier, Taylor et
al. 2012), and then casting them into a film for SMD. However, the above results reveal
the potential for zein films as a surface-coating material for biomedical devices including
drug/DNA-eluting stents, wound dressings, tissue engineering scaffolds and cell arrays
(Shea, Smiley et al. 1999; Zilberman, Kraitzer et al. 2010).
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3.6 Conclusions
The ability of zein films to support substrate-mediated gene delivery was demonstrated in
this chapter. The influence of pH of the zein solution on surface roughness and
hydrophilicity was investigated for its effect on transfection. Zein films formed at a
higher pH, exhibited lower surface roughness and higher hydrophilicity, showing
increased transfection levels, as well as prolonged stability against degradation and robust
biocompatibility. This study provides proof of concept that zein films with adsorbed
complexes can result in high levels of transfection and suggests that zein films have
applications in the fields of gene therapy, tissue engineering, and transfected cells arrays.
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CHAPTER 4: Conclusions and Future Directions
4.1 Introduction
This thesis describes further analysis of DNA-loaded zein nanospheres. Zein/DNA
nanospheres, formed through a simple coacervation process, demonstrated the ability to
protect DNA against nucleases, displayed robust biocompatibility, and were able to be
internalized by cells. In addition, zein films were developed for substrate-mediated gene
delivery. Zein films were formed by evaporation- induced self-assembly and were
comprised of particles that increased in size with zein concentration, up to 1.8 0.11 nm.
Films formed at different pHs (2-12) resulted in morphological differences, from a
smooth surface at pH 2 to films composed of spheres that decreased in size as the pH of
the zein solution used to form the film increased. Zein films degraded minimally in PBS,
and were able to adsorb DNA complexes, with 0.4 µg and 1.12 µg of total DNA on film
surface for lipid/DNA and polymer/DNA complexes, respectively, which was sometimes
independent of pH. However, transfection levels increased on films with increasing pH
and highest gene expression was achieved on pH 9 films with lipid/DNA complexes. This
increase in transfection on pH 9 films could be attributed to the decreased surface
roughness and increased hydrophilicity of the film. The results presented in this thesis
demonstrate both the zein spheres and films are novel and show great potential to the
field of gene delivery. However for both zein nanospheres and zein films, future
improvements are needed to improve and create a controlled and efficient DNA delivery
system for applications in oral gene delivery, tissue engineering and biomedical devices.
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4.2 Future Directions for Zein Nanospheres
Particulate delivery for DNA is promising due to the ability to protect DNA and provide
for controlled, localized, and sustained release resulting in transfection (Agarwal and
Mallapragada 2008). Zein, a natural protein, has many unique biological and physical
properties such as innate biocompatibility, slow degradation by hydrolysis, and
degradation products that enhance cell proliferation (Sun, Dong et al. 2005; HurtadoLopez and Murdan 2006) that makes it a good candidate for particulate gene delivery.
Zein nanoparticles can encapsulate DNA using a simple coacervation technique (Regier,
Taylor et al. 2012). These DNA-loaded zein particles ranged in size from 157.8 ± 3.9 nm
to 396.8 ± 16.1 nm, depending on the ratio of zein to DNA (20:1 to 250:1) and all
particles were negatively charged, which was expected due to the nature of zein (Cabra,
Arregun et al. 2005) and DNA at physiological pH. DNA encapsulation efficiency was as
high as 65.3 ± 1.9% with a maximum loading of 6.1 ± 0.2 mg DNA/g zein. The
cumulative release of DNA from these nanoparticles in PBS was 17.8 ± 0.2% over seven
days and encapsulation could protect DNA from DNaseI, which is critical for efficient
gene delivery, specifically for maintenance of the supercoiled conformation. The DNAloaded zein particles also displayed excellent biocompatibility and cellular
internalization.

As a next step for examining zein particles for oral delivery applications, preliminary
studies were performed to investigate the DNA-loaded zein particles in gastrointestinalsimulated conditions. The DNA-loaded particles released only 20% of their payload in
the first 30 minutes of incubation in simulated gastric fluid (SGF) (Figure 4-1) and DNA
remaining in these pepsin-treated spheres remained intact (Figure 4-2), demonstrating the
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ability of zein to protect DNA in the stomach, which is a critical for oral delivery
applications. However, in simulated intestinal fluid (SIF), containing pancreatin, release
was nearly instantaneous (Figure 4-1), and the DNA would likely be degraded from
intestinal enzymes, justifying the need for a secondary carrier to delay intestinal release
for the application of these particulates for oral gene delivery. Therefore, several changes
are recommended to this system for future use of these nanoparticles in oral gene delivery
applications, specifically forming particulates with a zein coating around a core of DNA
complexed with a material more suitable to the intestinal environment.

Figure 4-1. Enzyme-mediated release of DNA from zein nanoparticles (Regier
2011).

As demonstrated in literature and this thesis, zein possesses film-forming abilities, and
has been commonly used in pharmaceutical tableting and coatings (Lawton 2002), since
it has been shown to be especially well-suited for oral delivery applications (DiBiase and
Morrel 1997; Parris, Cooke et al. 2005; Gong, Sun et al. 2011). In addition, as
demonstrated above, zein particles can protect payload from the low pH and enzymes of
the stomach, including DNA, as demonstrated from preliminary data (Figure 4-2).
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Figure 4-2. Integrity of released DNA from zein nanoparticles (in simulated gastric). Lanes
“L” markers; lanes “S” stock DNA; lanes 0 -180 minutes in fluids.

However, zein is rapidly degraded in the intestine (as data shows above, Figure 4-1),
making it an ideal material to serve as a coating for DNA-loaded nanoparticles rather
than the DNA carrier alone. Therefore, in this proposed system, the zein-coated DNA
nanoparticle would pass through the stomach, protected by the zein coating, which would
degrade upon reaching the intestine, and then the inner DNA nanoparticle would be able
to target cells and achieve transfection in the intestine. From surveying the literature,
chitosan nanoparticles could provide for protection of DNA in the intestine, once the zein
coating degrades.

Chitosan (CS), the N-deacetylation form of chitin, has not only inherent biocompatibility
and biodegradability, but also unique mucoadhesive properties that allow for increased
residence time at the cell surface of the intestines (Lai, Wang et al. 2009). Therefore, CS
has been used to form nano- and microspheres loaded with DNA for oral delivery to treat
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hypoparathyroidism (Chou, Huang et al. 2009), hemophilia (Dhadwar, Kiernan et al.
2010), and food allergies (Roy, Mao et al. 1999; Bengali, Rea et al. 2009). However, the
efficacy of CS-mediated oral gene delivery is stunted due to the high solubility of CS in
acidic conditions of the stomach, leading to fast release of cargos before arrival to the
intestine (Luo, Zhang et al. 2010), and thus low transfection efficiency. Proper
protections to CS/DNA nanoparticles are necessary to achieve effective gene transfection
of intestinal cells.

Hence, the future direction for this project should investigate novel zein-coated, DNAloaded chitosan nanoparticles with optimal properties for oral gene delivery. The zein
coating will provide adequate protection to the CS/DNA nanoparticles until they reach
the intestine, where zein will be instantly degraded. The exposed CS/DNA nanoparticles
will have prolonged residence time in the intestine, due to the mucoadhesive nature of
chitosan (Lai, Wang et al. 2009), leading to increased ability for transfection of intestinal
cells. The significant advantage of this design is that the zein-coated CS/DNA
nanoparticles can appropriately fulfill the requirements from different environments
along the GI tract and allow for protection and targeted release of the DNA. Particles
from zein/chitosan composites have been developed for oral delivery of selenite (Luo,
Zhang et al. 2010) and α-tocopherol (Luo, Zhang et al. 2011), and the use of the two
biomaterials resulted in prolonged release of encapsulated cargo versus particles from a
single material. However, there have been no published reports on zein/chitosan
nanoparticles for DNA delivery, making this exciting future work.

88

In preliminary studies, CS/DNA nanoparticles were prepared using a simple and mild
method, ionic gelation, which is the complexation between oppositely charged
macromolecules. During ionic gelation, low molecular weight (Mw) chitosan was
dissolved in aqueous acidic solution to obtain the cation of chitosan, and DNA was
dissolved in a polyanion, sodium Tripolyphosphate (TPP) solution. The two oppositely
charged solutions were mixed and chitosan underwent ionic gelation and precipitated to
form CS/DNA nanoparticles (Mitra and Dey 2011). This method demonstrated a linear
increase of nanoparticle size with increasing CS concentration (1-2.5 % (w/v)) as seen in
Figure 4-3, and loading efficiency similar to that reported in the literature for CS/DNA
nanoparticles for gene delivery (Ozbas-Turan and Akbuga 2011). Also, the zeta potential
was positive for all concentrations of CS/DNA spheres. This positive zeta potential is an
important feature for gene delivery systems due to the increased interactions with
negatively charged cellular membranes to enhance internalization of the nanoparticles
and result in greater transfection (Harush-Frenkel, Debotton et al. 2007).

Figure 4-3. Size of CS/DNA nanoparticles at different concentrations of
CS.
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Next, the release of DNA from these spheres was tested in SIF (Figure 4-4). In contrast to
the instant burst release of DNA from zein spheres (Figure 4-1), DNA-loaded chitosan
spheres demonstrated a slow and minimal release of DNA in SIF over 8 days (Figure 44). This minimal release of DNA is important because it allows for more DNA to be
internalized with the CS nanosphere, strengthening the use of chitosan as a DNA carrier
for oral gene delivery.

Figure 4-4. Release of DNA from CS/DNA nanoparticles in SIF.

Preliminary studies were also conducted to investigate the ability to coat CS/DNA
nanoparticles with zein (Figure 4-5), showing that the size of coated nanoparticles
increased with increasing zein/CS ratio. These results indicate that zein is a promising
coating material for CS/DNA particles for oral gene delivery.
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Figure 4-5. Size of CS/DNA and zein-coated CS/DNA nanoparticles at various zein/CS
ratios.
Also, CS/DNA nanoparticles, prepared as described above, were added to cells and
demonstrated excellent biocompatibility measured through a standard WST-1 assay
(Figure 4-6A) and microscopic observation of cell morphology (Figure 4-6B). These
results indicate that the zein-coated CS/DNA nanoparticles exhibit the required
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Figure 4-6. (A) Cytotoxicity of the zein-coated CS/DNA nanoparticles quantified by
WST-1 assay for HEK 293T cells as a function of DNA amount in nanoparticles. (B) Cell
morphology in presence of nanoparticles.
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All of the preliminary data above suggests the great potential of zein-coated DNA-loaded
chitosan nanoparticles for oral gene delivery applications. However, there is still more
work needed to optimize the zein-coated CS/DNA nanoparticles in order to create a
controlled and efficient delivery system. Next steps on this project should include
investigation of the ability of CS/DNA spheres to transfect cells effectively. Previous
studies have shown that there are many factors affecting the size, charge, and stability of
the CS/DNA spheres including Mw of chitosan, degree of deacetylation (DD), N/P ratio
of amine CS to phosphate DNA and mass ratio of CS:TPP, which affects the affinity of
CS to DNA, cellular uptake, dissociation of complex and therefore transfection levels
(Koping-Hoggard, Tubulekas et al. 2001; Sato, Ishii et al. 2001; Romøren, Pedersen et al.
2003; Kiang, Wen et al. 2004; Liu, Sun et al. 2005; Strand, Danielsen et al. 2005;
Lavertu, Méthot et al. 2006; Mao, Sun et al. 2010). Thus, optimization of transfection
with CS/DNA nanoparticles should include investigating each of the above parameters.
After the CS/DNA spheres are optimized for transfection and cytotoxicity, the
concentration of zein needs to be explored for efficient coating of CS/DNA spheres to
provide complete protection through the stomach environment. Then, zein-coated
CS/DNA nanoparticles should be tested in vitro for transfection by delivering treated
spheres (passed through SGF and SIF) to cells. Once the development of zein-coated
CS/DNA nanoparticles are properly formed and optimized for efficient in vitro
transfection, animal studies can then be carried out to examine the spheres efficacy in
vivo, looking first at reporter gene expression in the intestine and then examining off
target effects in other organs.
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Gene delivery via the oral route for gene therapy and DNA vaccination has the potential
to revolutionize the treatment and prevention of various diseases, thus making these
outlined future directions of this project significant for human health. A novel and
effective particulate system for oral DNA delivery could eliminate the need for
administration by healthcare professionals and enhance convenience to the patient; the
transient nature of nonviral gene delivery would require repeated administration for gene
therapy applications to maintain a therapeutic effect and thus ease of administration as
well as patient comfort and compliance are particularly important. The investigation of
new materials and designs of gene carriers, which have properties required for efficient
oral gene delivery, promises to fuel more breakthroughs and bring nonviral gene delivery
via oral administration closer to clinical application.

4.3 Future Directions for Zein Films
In chapter 3, DNA lipoplexes and polyplexes were adsorbed to the surface of zein films
for substrate-mediated delivery (SMD) for the first time. Transfection levels increased
with increasing pH and highest gene expression was achieved on pH 9 films with
LF/DNA complexes. However, these films need to be better fabricated to improve upon
the DNA delivery efficiency in order to be applied as a coating on biomedical devices
and thus the following improvements are recommended to the system.

Controlled and sustained release of plasmid from a tissue engineering scaffold or device
coating is a crucial part of successful gene delivery by allowing for large numbers of cells
to be transfected, but also providing localized delivery and circumventing the need for
repeated injections. The zein films formed in Chapter 3 were not examined for release of
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DNA from films and therefore a release profile of both lipid and polymer complexes
needs to be investigated. If the release of DNA is found to be too fast from the surface,
then DNA complexes could be embedded into the zein films to provide for a longer
continuous release rate. This technique would allow the DNA complexes to be released
as the film degraded and not simply through adsorption/desorption processes as described
in Chapter 3. Previous works have embedded naked DNA and complexed DNA in
polymer scaffolds. Shea et al, used a high pressure gas foaming procedure to incorporate
DNA into a PLGA sponge, demonstrating sustained DNA release for a month and
transfecting a large number of cells (Shea, Smiley et al. 1999). Another group
incorporated a plasmid encoding for sperm-specific lactate dehydrogenase C4 (LDH- C4)
into a poly(ethylene-co-vinyl acetate) (EVAc) matrix for vaginal DNA immunization
through induced local mucosal immunity in mice. The DNA-loaded EVAc displayed
continuous DNA release and long term production of LDH- C4 in the vaginal tract as
compared to naked DNA (Shen, Goldberg et al. 2003). Poly-caprolactone (PCL) films
with complexed DNA embedded throughout the film showed enhanced transfection
levels and suppressed burst release compared to embedded naked DNA (Ramgopal,
Mondal et al. 2008). In order to embed DNA complexes into the zein film, complexes
would be added to the zein solution prior to film formation by EISA. Problems such as
complex aggregation and uneven distribution of complexes on the film surface may occur
and would need to be further investigated through fluorescently labeling DNA and
analyzing the dispersion of DNA complexes on the surface with confocal imaging.

Even though the release of DNA from the substrate is an important aspect to successful
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gene transfer, the substrate properties are also important. Zein films are hydrophobic,
glossy, greaseproof, and resistant to bacteria (Lawton 2002), but suffer from being brittle
and susceptible to cracking and chipping as well as instability in water (Lawton 2002;
Jiang, Reddy et al. 2010; Shi, Huang et al. 2010). These unwanted properties of zein
films hinder its use in biomedical applications. However, mechanical and physical
properties of zein films have been improved through the addition of a plasticizer or
crosslinker for increased flexibility and increased tensile strength, Young’s modulus and
water stability, respectively (Parris and Coffin 1997; Xu, Karst et al. 2008; Reddy, Li et
al. 2009; Jiang, Reddy et al. 2010; Shi, Huang et al. 2010).

Plasticizers are low molecular mass organic compounds which soften rigid polymers by
reducing the glass transition temperature of polymers, reducing their crystallinity or
melting point through separating individual polymer chains from one another (Hinrichsen
1996; Sperling 2005). A variety of plasticizers have been added to the fabrication process
of zein films. Hydrophilic plasticizers, such as glycerol and polyethylene glycol, have
increased the flexibility of zein films but with decreased strength and stiffness (Aydt
1989; Park, Bunn et al. 1994; Weller, Gennadios et al. 1998). Fatty acids, including
palmitic acid, oleic acid, linoleic acid, and steric acid exceeded hydrophilic plasticizers
by maintaining the strength of the films and improving the film flexibility (Lai and Padua
1997; Lai, Padua et al. 1997; Budi Santosa and Padua 1999). Another group of
hydrophobic plasticizers are citrate esters, which are derived from citric acid. Citric esters
are non-toxic and biodegradable. Zein films containing 10% tributyl citrate (TBC)
demonstrated flexible and tough films (Shi, Yu et al. 2012). Incorporation of a
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biocompatible and nontoxic plasticizer to the zein films formed in Chapter 3 could
enhance flexibility for future applications of these films, including coating biomedical
devices for gene delivery.

The addition of crosslinkers to zein films have included glyoxal, formaldehyde,
glutaraldehyde, and citric acid, and butanetetracarboxylic acid (Yang, Wang et al. 1996;
Woods and Selling 2007; Reddy, Li et al. 2009; Jiang, Reddy et al. 2010; Selling, Woods
et al. 2012). Of all these crosslinkers that have been investigated, citric acid is the most
promising due to its biocompatibility. Zein fibers crosslinked with citric acid have shown
decreased rates of degradation, enhanced biocompatibility and improved water stability
compared to uncrosslinked fibers (Jiang, Reddy et al. 2010). Thus, addition of a
crosslinker, preferably, citric acid, should be investigated for its potential to improve the
degradation rate and water stability of zein films, particularly films formed at pH 12 due
to their instability upon addition of PBS.

Finally, future work is needed to examine the effect of storage time and humidity on zein
film properties. Since zein is a biological material, it is affected by water and thus its
properties are subject to change with humidity (Lawton 2002). Lai and Padua
demonstrated increased water permeability, toughness, and elongation of zein films with
high relative humidity (Lai and Padua 1998). However, they also showed the addition of
oleic acid, a plasticizer, helped maintain these properties of zein films through increased
humidity (Lai and Padua 1998). During the preliminary film studies reported in Chapter
3, there were changes in transfection levels with zein films of different ages. For instance,
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with fresh (made the day before experiment) zein films, the transfection increased with
increasing pH, but when zein films were aged (made weeks to months prior to use), the
transfection levels decreased with increasing pH as seen in Figure 4-7. The incorporation
of a plasticizer or crosslinker to not only improve mechanical and physical properties of
zein films as mentioned above, but to decrease the film’s water vapor permeability might
help overcome these changes in film surface properties. Thus, there is a need to study the
alteration in zein film properties over time to further understand the effect of surface
properties of zein films on the transfection efficiency.
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Figure 4-7. Normalized SMD transfection profile for (A) HEK 293T cells, n=6 and (B)
NIH3T3 cells, n=3, plated on aged zein films formed from different pH solutions,
mediated by LF/DNA complexes. Data reported as mean standard error of the mean.
(*p < 0.05, **p < 0.01).
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4.4 Conclusions
In this thesis, a natural protein polymer, zein, was investigated for its ability to form
DNA-loaded nanospheres and films for gene delivery. Once fabricated using a simple
coacervation technique that resulted in sufficient DNA loading, zein/DNA nanospheres
showed resistance to degradation against DNase I, cell biocompatiblity and
internalization, as well as protection of DNA in a gastric environment. However, it has
been noted that zein might not be able to obtain sufficient oral gene delivery by itself and
thus the addition of another polymer, such as CS, would allow for DNA nanoparticle
stability in the intestine and these multilayer particles could revolutionize treatments and
impact the field of oral gene delivery. Additionally, zein films used for SMD delivery of
DNA were established for the first time. Zein films formed either a smooth, flat surface
or that of particles depending on pH of zein solution, and demonstrated excellent cell
biocompatibility and transfection with increasing pH of films. Future work still remains
to better characterize these films for improved DNA delivery and improved mechanical
properties, for applications in oral gene delivery, tissue engineering, and biomedical
devices.
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